ingentaconnect Table Of Contents: Journal of the European Academy of Dermatology and Venereology

Quantitative characterization of sclerotic skin in localized and systemic scleroderma: image analysis on 20 MHz-B-scan recordings
pp. S204A-S204A(1)
Authors: Seidenari S.; Conti A.; Di Nardo A.

Laser Doppler flowmetry comparison of pharmacodynamic effects of cetirizine and loratadine on histamine induced skin response
pp. S204A-S204A(1)
Authors: Tasset C.; Valentin B.; Coulie P.; Van Neste D.; de Brouwer B.

Progressive systemic scleroderma/systemic lupus erythematosus overlap syndrome rapidly progressive with spontaneous regression of a facial angioma
pp. S204A-S204A(1)
Authors: Ricci C.; Piacentino M.T.; Macchini V.; Sonego G.; Atzori F.

Research and practice
pp. 1-1(1)
Author: Lapiere C.M.

Place of surgery in dermatology
pp. 1-1(1)
Author: Haneke E.

Bioengineering
pp. 1-1(1)
Author: Andreassi L.

Acne therapy tody: advances and drawbacks
pp. 2-2(1)
Author: Gotinick H.P.M.

Current trends in melanoma therapy
pp. 2-2(1)
Author: Stingl. G.

Gene therapy
pp. 2-3(2)
Author: Cassiman J.J.

Cost-effectiveness in dermatology
pp. 3-3(1)
Author: Braathen L.R.

Prevention in dermatology
pp. 3-3(1)
Author: Wolff K.

Tumor necrosis factor: mechanisms of action and therapeutic possibilities
pp. 3-3(1)
Authors: Fiers W.; Beyaert R.; Boone E.; Brouckaert P.; Cauwels A.; Declercq W.; Decoster E.; De Valck D.; Everaerdt B.; Goossens V.; Grooten J.; Haegeman G.; Lenaerts A.; Libert C.; Takahashi N.; Vandenabeele P.; Berghe W.V.; Vandevoorde V.

Human immunodeficiency virus: current status
pp. 3-4(2)
Author: Conant M.A.

International dermatology
pp. 4-4(1)
Author: Mascaro J.M.

Anti-inflammatory capacities of neuropeptides in the skin
pp. 4-4(1)
Author: Luger T.A.

Antiparasitic treatment
pp. 4-4(1)
Author: Burns D.A.

What's new in the understanding of vitiligo
pp. 4-5(2)
Author: Ortonne J.P.

New concepts in parapsoriasis and mycosis fungoides
pp. 5-5(1)
Author: Thestrup-Pedersen K.

Scientific study of Candida albicans infections
pp. 5-5(1)
Author: Odds F.C.

Recent progress in clinical genetics of human hair diseases
pp. 7-7(1)
Author: Happle R.

Hair therapeutics -- where are we going?
pp. 7-7(1)
Author: Dawber R.P.R.

The future of hair models: in vitro versus in vivo methods
pp. 7-7(1)
Author: Van Neste D.

Abnormal hair cycles in early androgenetic female alopecia
pp. 7-7(1)
Authors: Guarrera M.; Rebora A.

Corneosurfametry
pp. 7-8(2)
Authors: Pierard G.E.; Goffin V.; Pierard-Franchimont C.

Optical properties of the skin in the U.V. range application to sun protection formulations
pp. 8-8(1)
Authors: de Rigal J.; Guiolet A.; Monot M.; Leveque J.L.; Moyal D.; Hourseau C.

Skin bioengineering: recent advances
pp. 8-8(1)
Author: Serup J.

Laser doppler perfusion imaging -- state of the art
pp. 8-8(1)
Authors: Wadell K.; Arildsson M.; Linden M.; Nilsson G.E.

Image analysis procedures on 20 MHz-B-scan recordings
pp. 9-9(1)
Author: Seidenari S.

Airborne dermatitis
pp. 9-9(1)
Author: Dooms-Goossens A.

Sesquiterpene lactones dermatitis
pp. 9-9(1)
Author: Ducombs G.

Airborne wood dermatitis
pp. 9-9(1)
Author: Meding B.

Airborne dermatitis from fragrance and incense
pp. 9-9(1)
Author: Tosti A.

New concepts in understanding sebaceous gland function
pp. 10-10(1)
Author: Zouboulis C.C.

New concepts in understanding comedone formation
pp. 10-10(1)
Authors: Kealey T.; Guy R.

New concepts of drug induced ache
pp. 10-10(1)
Author: Plewig G.

Treatment of acne is more than treatment of acne...
pp. 10-10(1)
Author: Fyrand O.

New retinoids, their role in acne therapy
pp. 10-10(1)
Author: Shalita A.R.

P.acnes resistance, prevention and treatment
pp. 11-11(1)
Author: Cunliffe W.J.

Acne fulminans -- new approach to therapy
pp. 11-11(1)
Author: Karvonen S.-L.

Antifungals -- short courses and pulsed therapies
pp. 11-11(1)
Author: Degreef H.

Side effects and interactions of oral antifungals
pp. 11-11(1)
Author: Svejgaard E.

Moldinfections are they pathogenic
pp. 11-11(1)
Author: Vetmeer B.J.

Susceptibility to dermatomycosis
pp. 11-12(2)
Author: Faergemann J.

Antifungal drug resistance
pp. 12-12(1)
Author: Hay R.J.

Acquired and congenital melanocytic nevi: when (and how) are they at risk? How should they be managed?
pp. 12-12(1)
Authors: Naeayert J.M.; Vossaert K.; Monstrey S.J.

Pathological markers of melanocytic tumor progression
pp. 12-12(1)
Authors: van Muijen G.; Danen E.; de Vries T.; Ruiter D.

Management of patient: what should be done after diagnosis?
pp. 12-12(1)
Author: Giannotti B.

T-lymphocytes in the pathogenesis of skin disorders
pp. 12-13(2)
Author: Rocken M.

C3g,g in normal and diseased human skin
pp. 13-13(1)
Authors: Basset-Segin N.; Yancey K.B.

Oral ciclosporin in dermatology
pp. 13-13(1)
Authors: Belaich S.; Mazer J.-M.

Leishmaniasis's therapy
pp. 13-13(1)
Author: Gharbi R.

Melasma -- various treatment modalities
pp. 13-13(1)
Author: Katsambas A.

Atypical Naevi and potential for malignant change
pp. 14-14(1)
Author: MacKie R.M.

CDKN2/MTS-1 gene deletion in Dutch FAMMM families
pp. 14-14(1)
Authors: Bergman W.; Vermeer B.J.; Gruis N.A.; Frants R.R.

Congenital nevi and their potential for malignant change
pp. 14-14(1)
Author: McLean D.I.

Physiopathology of contact dermatitis
pp. 14-14(1)
Authors: Krasteva M.; Chabeau G.; Claudy A.; Nicolas J.-F.

Treatment of allergic contact dermatitis: new aspects
pp. 14-14(1)
Author: Lachapelle J.M.

Quantitative aspects in contact allergy
pp. 15-15(1)
Author: Andersen K.E.

Sensitization sources of colophony
pp. 15-15(1)
Author: Karlberg A.-T.

What's new in latex allergy?
pp. 15-15(1)
Author: Turjanmaa K.

New allergens
pp. 15-15(1)
Author: Camarasa J.G.

Nail surgery
pp. 15-16(2)
Authors: Neil P.J.; Walker F.R.C.P.

Scalp surgery: hair transplants today
pp. 16-16(1)
Author: Camps-Fresneda A.

Dermatological surgery of the penis
pp. 16-16(1)
Author: Haneke E.

Stage I cutaneous melanoma surgery
pp. 16-16(1)
Author: Landi G.

Treatment of morpheic basal cell carcinoma
pp. 16-16(1)
Authors: Picoto A.; Labareda J.M.; Themido R.

Chemical peeling
pp. 16-16(1)
Author: Katsambas A.

Up to date on histiocytic syndromes
pp. 17-17(1)
Author: Caputo R.

Hyalinosis
pp. 17-17(1)
Authors: Oranje A.P.; Vuzevski V.D.; Kleijer W.; Mancini G.

Mastocytosis
pp. 17-17(1)
Author: Czarnetzki B.M.

Vascular tumors
pp. 17-17(1)
Authors: Goossens C.; Song M.

Congenital melanocytic nevi and melanoma
pp. 17-17(1)
Authors: Taieb A.; Vergnes P.

UVB and PUVA treatment of psoriasis and atopic dermatitis guided by skin reflectance measurements
pp. 17-18(2)
Author: Wulf H.C.

Comparison of epidermal thickening developed by patients after UVB photototherapy or PUVA
pp. 18-18(1)
Authors: del Rio R.; Lecha M.; Coll J.; Trullas J.

Risk assessment for narrow-band (TL-01, UVB) vs broad-band (UVB) vs photochemotherapy (PUVA)
pp. 18-18(1)
Author: Ferguson J.

Photocarcinogenesis of khellin and UVA or sunlight
pp. 18-18(1)
Author: Bech-Thomsen N.

Type I hypersensitivity
pp. 18-18(1)
Author: Czarnetzki B.M.

The autoimmune bullous diseases
pp. 19-19(1)
Author: Wojnarowska F.

Immune complex diseases
pp. 19-19(1)
Authors: Nurnberg W.; Czarnetzki B.M.

Delayed hypersensitivity
pp. 19-19(1)
Authors: Enk A.H.; Knop J.

New trends in immunodermatology
pp. 19-19(1)
Author: Bos J.D.

A study of nail disease in patients with human immunodeficiency virus infection
pp. 19-20(2)
Authors: Olemans C.; Andre J.; Lateur N.

Longitudinal melanonychia (LM) in childhood. Clinical and histological study
pp. 20-20(1)
Authors: Goettmann S.; Andre J.

Nail changes in patients with neurologic deficit
pp. 20-20(1)
Authors: Tosti A.; Piraccini B.M.; Rinaldi R.

Footwear-induced nail disorders
pp. 20-20(1)
Author: Richert B.

Bowen's disease of the nails
pp. 20-20(1)
Author: Haneke E.

Spontaneous photo-onycholysis
pp. 20-20(1)
Author: Baran R.

Clinical aspects of nail growth
pp. 21-21(1)
Author: Dawber R.P.R.

In vivo confocal microscopy. A non-invasive trip in the epidermis
pp. 21-21(1)
Authors: Corcuff P.; Pierard G.E.

The stratum corneum: a window on skin diseases
pp. 21-21(1)
Authors: Pierard G.E.; Pierard-Franchimont C.

Cell proliferation and cell death in cancer
pp. 21-21(1)
Authors: Rieger E.; Cerroni L.; Schaider H.; Kerl H.

A new look on herpesviridae infections
pp. 21-22(2)
Author: Nikkels A.F.

Histologic effects of topical retinoic acid
pp. 22-22(1)
Author: Griffiths C.E.M.

New diseases: real novelties or rediscoveries?
pp. 22-22(1)
Author: Grosshans E.

Urea in combination with currettage in the treatment of eyelid and the canthal area carcinomas
pp. 22-22(1)
Author: Danopoulou I.E.

Laser peeling and laser abrasion
pp. 22-22(1)
Author: Letessier S.

Fat tissue surgery
pp. 22-23(2)
Authors: Rusciani L.; Petraglia S.

Intradermal augmentation with expanded polytetrafluoroethylene (Gore-Tex) for facial lines and wrinkles
pp. 23-23(1)
Author: Cisneros J.L.

Complex repairs of the nose
pp. 23-23(1)
Author: Robins P.

Bakamjian's flap
pp. 23-23(1)
Author: Camacho F.

Skin loss repair with perilesional grafts
pp. 23-23(1)
Author: Leigheb G.

Surgical vs. CO2 laser vermilionectomies. Evaluation of the techniques
pp. 23-23(1)
Author: Conejo-Mir. J.S.

Dermatological surgical care of patients with skin cancers occurring after use of tanning beds
pp. 24-24(1)
Author: Amonette R.

Plastics -- what is new
pp. 24-24(1)
Authors: Kanerva L.; Jolanki R.; Estlander T.

Rubber -- what's new?
pp. 24-24(1)
Author: Brandao F.M.

Nickel
pp. 24-24(1)
Author: Burrows D.

Protective gloves
pp. 24-24(1)
Author: Wahlberg J.E.

Prevention of hand eczema by teaching
pp. 24-25(2)
Author: Fischer T.

Pityriasis Rosea and Mucha-Habermann
pp. 25-25(1)
Authors: Gelmetti C.; Pistritto G.; Menni S.; Trevisan G.

APEC: overview
pp. 25-25(1)
Author: Taieb A.

Gianotti-Crosti syndrome
pp. 25-25(1)
Author: Caputo R.

Acute hemorrhagic edema of infancy
pp. 25-25(1)
Author: De Raeve L.

Contact urticaria syndrome (CUS) in childhood
pp. 25-25(1)
Authors: de Waard-van der Spek F.B.; Oranje A.P.

Sunscreen Ingredients
pp. 26-26(1)
Author: Murphy G.M.

Protection against UVB
pp. 26-26(1)
Author: Hawk J.L.M.

Protection against UVA
pp. 26-26(1)
Author: Roelandts R.

Protection of UV-induced immuno suppression
pp. 26-26(1)
Author: Mommaas A.M.

Real interest of antioxidants ingredients
pp. 26-26(1)
Author: Beani J.C.

Side effects of sunscreens: results of a multicenter study
pp. 26-27(2)
Authors: Lehmann P.; Neumann N.J.

Practical use of sunscreens
pp. 27-27(1)
Author: Thomas P.

Epidemiology of NMSC with special reference to risk factors
pp. 27-27(1)
Authors: Vermeer B.J.; Bavinck J.N.B.; ter Schegget J.

Oral isotretinoin chemoprevention of skin cancer in xeroderma pigmentosum
pp. 27-27(1)
Authors: DiGiovanna J.J.; Kraemer K.H.; Sollitto R.B.; Peck G.L.

Non melanoma skin cancer: epidemiology, registration, carcinogenesis
pp. 27-28(2)
Author: Frentz G.

Invasion-suppressor and invasion-promoter molecules
pp. 28-28(1)
Authors: Mareel M.; van Roy F.; Bracke M.

Non-melanoma skin cancer and pre-malignancy in renal transplant recipients
pp. 28-28(1)
Authors: De Bersaques J.; Vandeghinste N.; Wieme N.; Beele H.

Neurotransmitters and clinical dermatology
pp. 28-28(1)
Author: Lotti T.M.

Pediatric dermatology
pp. 28-28(1)
Author: Oranje A.P.

Epiluminescence microscopy: clinical aspects
pp. 29-29(1)
Author: Wolff K.

Adapalene: a retinoid for the topical treatment of acne
pp. 29-29(1)
Author: Verschoore M.

What's new in dermatology? What else is new?
pp. 29-29(1)
Author: Dobson R.L.

Sociology of syphilis in the nineteenth century
pp. 29-29(1)
Authors: Tilles G.; Wallach D.

AIDS: the modern day plague
pp. 29-29(1)
Author: Conant M.A.

Dermatology and art
pp. 29-29(1)
Author: Kint A.

Dermatology: does Tintin, our (inter)national hero play a role?
pp. 30-30(1)
Author: Delescluse J.

The elephant man
pp. 30-30(1)
Author: Goens J.

Plica polonica: metamorphosis of a mysterious disease
pp. 30-30(1)
Author: Panconesi E.

Sun and society
pp. 30-30(1)
Author: Holubar K.

Genes and psoriasis
pp. 30-30(1)
Author: Guilhou J.J.

Cell kinetics in various types of psoriasis: therapeutical implications
pp. 30-30(1)
Authors: de la Brassinne M.; Bonardeaux C.

New trends in general treatments
pp. 30-31(2)
Author: Dubertret L.

Epidemiological facts about atopic dermatitis
pp. 31-31(1)
Author: Thestrup-Pedersen K.

Immunological mechanisms in atopic dermatitis. Is it a Th-2 type disease?
pp. 31-31(1)
Author: Neumann C.

Food allergy in atopic dermatitis. Can avoidance diet be beneficial?
pp. 31-31(1)
Author: de Prost Y.

Clinical approach and therapy of atopic dermatitis -- what can be done and what should be avoided
pp. 31-32(2)
Author: de Ascensao A.C.

The bullous pemphigoid antigen (BP180) in genetic and acquired diseases
pp. 32-32(1)
Author: Jonkman M.F.

Laminin 5 and collagen VII in genetic and acquired diseases
pp. 32-32(1)
Author: Bruckner-Tuderman L.

Linear IgA disease: antigens and immunogenetics
pp. 32-32(1)
Author: Wojnarowska F.

Genetics of dermatitis herpetiformis
pp. 32-33(2)
Author: Reunala T.

Antihistamine therapy of urticaria
pp. 33-33(1)
Author: Black A.K.

Diagnostic methods as a way to curative treatment of chronic urticaria
pp. 33-33(1)
Authors: Czarnetzki B.M.; Chantraine-Hess S.; Zuberbier T.

Failure to tolerate high affinity IgE receptors: a cause for chronic urticaria and therapeutic implications
pp. 33-33(1)
Authors: Greaves M.W.; O'Donnell B.F.

Immunomodulating treatment of urticaria
pp. 33-33(1)
Author: Torrelo A.

Non-antihistaminic treatment of urticaria
pp. 33-34(2)
Author: Van Hecke E.

Basophil numbers in chronic urticaria
pp. 34-34(1)
Authors: Grattan C.E.H.; Walpole D.A.; Francis D.M.

The Barbie doll syndrome
pp. 35-35(1)
Author: Cotterill J.A.

The dermatologist and the hypochondriac: a delicate meeting. A case of glossodynia
pp. 35-35(1)
Author: Consoli S.G.

Counselling in STD (and AIDS)
pp. 35-35(1)
Authors: Panconesi E.; Tiradritti L.; Zuccati G.

Delusions in dermatology
pp. 35-35(1)
Author: Musalek M.

Somatoform disorders in dermatology
pp. 35-36(2)
Authors: Gieler U.; Kohmlein B.; Stangier U.

Clinical features and drug treatment of psychodermatological disorders
pp. 36-36(1)
Author: Van Moffaert M.

Psycho-social aspects of psoriasis
pp. 36-36(1)
Authors: de la Brassinne M.; Sarto D.; Bonardeaux C.

The modern approach to drug eruptions
pp. 36-36(1)
Author: Shear N.H.

Drug induced bullous disorders
pp. 36-36(1)
Author: Breathnach S.M.

Comparison of different in vitro tests on the basis of serial haptens related to cytokine release and to oral provocation after drug eruptions
pp. 36-36(1)
Author: Balo-Banga J.M.

Diagnostic morfometry in allergic and pseudoallergic drug reactions
pp. 36-37(2)
Authors: Eordogh I.; Eordogh I.; Balo J.M.; Nagy G.

Theoretical and practical problems related to the diagnosis of drug allergy
pp. 37-37(1)
Author: Pinto J.d.S.

Adverse reactions due to homeopathic or natural medicine
pp. 37-37(1)
Authors: Stoger P.; Hintner H.

Vascular malformations and hemangiomas. Introduction
pp. 37-37(1)
Author: Mascaro J.M.

Extracutaneous associations of vascular malformations and hemangiomas
pp. 37-38(2)
Author: Happle R.

Vascular anomalies and investigations
pp. 38-38(1)
Author: Enjolras O.

Approach to non-surgical management of vascular malformations and hemangiomas
pp. 38-38(1)
Authors: Teillac-Hamel D.; de Prost Y.

Vascular malformations and angiomas
pp. 38-38(1)
Author: Cotterill J.A.

Which role plays surgery in the field of hemangiomas and vascular malformations?
pp. 38-39(2)
Authors: HECOVAN Studygroup for Hemangioma and Congenital Vascular Anomalies Nijmegen; Rieu P.N.M.A.

Introduction to lasers in dermatology
pp. 39-39(1)
Author: Landthaler M.

Laser treatment of non-vascular skin lesions
pp. 39-39(1)
Authors: Hohenleutner U.; Landthaler M.

Laser treatment in venereology
pp. 39-39(1)
Author: Bierring P.

The history of rosacea
pp. 39-39(1)
Author: De Bersaques J.

Classifications and management of rosacea
pp. 39-40(2)
Author: Powell F.C.

Ophthalmo-rosacea
pp. 40-40(1)
Author: Jansen T.

Does Helicobacter pylori play any etiopathogenetic role in rosacea?
pp. 40-40(1)
Authors: Drago F.; Rebora A.

Alternative rosacea therapy
pp. 40-40(1)
Author: Cunliffe W.J.

Imitators of rosacea
pp. 40-40(1)
Author: Piewig G.

Erythema multiforme [von Hebra]
pp. 43-43(1)
Author: Weston W.L.

Toxic epidermal necrolysis -- clinical, pathogenetical and therapeutical aspects
pp. 43-43(1)
Authors: Schopf E.; Mockenhaupt M.

A quantitative assessment of melanin content in surface corneocytes from subjects of varying phototypes
pp. 43-43(1)
Authors: H. L.; Pearse A.D.; Gaskell S.; Marks R.

Photographic problems in dermatology and how to minimize them
pp. 43-44(2)
Author: Kissane M.J.

Advances in the diagnosis and management of urethritis
pp. 44-44(1)
Author: Freedman D.

Epidemiology of gonorrhoea and PPNG in Europe
pp. 44-44(1)
Authors: Kohl P.K.; Kratofiel M.

Imported urethritis (or the travelling dick)
pp. 44-44(1)
Author: Waugh M.A.

Infective balanitis
pp. 44-44(1)
Author: Stratigos J.D.

Pathogenetic aspects of Lichen scleroses in man
pp. 44-44(1)
Authors: Hagedorn M.; Buxmeyer B.

7.5 MHz-Sonography in Dermatology
pp. 45-45(1)
Authors: Merk G.; Ulrich J.; Petereit S.; Pohle R.

Topical retinoic acid for photoageing: clinical use and mechanism of action
pp. 46-46(1)
Author: Griffiths C.E.M.

ROL action in human skin
pp. 46-46(1)
Author: Voorhees J.J.

Alpha hydroxy acids: a critial review of skin effects
pp. 46-47(2)
Author: Rogiers V.

Glycolic acid peel: management and critical approach
pp. 47-47(1)
Author: Durupt G.

Principles of PDT
pp. 47-47(1)
Author: Thiele B.

Photochemotherapy (PUVA) versus photodynamic therapy (PDT): differences of mechanism of action
pp. 47-47(1)
Authors: de la Brassinne M.; Barthe L.; Azouaghe K.

Systemic photodynamic therapy in dermatology
pp. 47-47(1)
Author: Emtestam L.

Topical pdt in dermatology
pp. 47-47(1)
Author: Calzavara-Pinton P.G.

Perspectives and future directions of PDT in dermatology
pp. 47-48(2)
Author: Szeimies R.M.

Examination of the angioarchitecture of superficial varicose veins by means of corrosion preparations
pp. 48-48(1)
Authors: Wienert V.; Bohler U.

Differential diagnosis of telangiectasia
pp. 48-48(1)
Author: Sarkany I.

Investigation of venous patients
pp. 48-48(1)
Author: Neumann H.A.M.

Leg teleangiectasia -- indications of Muller's phlebectomy
pp. 48-48(1)
Author: Ramelet A.A.

Laser therapy of varicosities
pp. 48-49(2)
Author: Vanscheidt W.

Photoderm VL treatment of leg teleangiectasia
pp. 49-49(1)
Authors: Schroeter C.A.; Wilder D.; Keiner M.; Raulin C.; Neumann H.A.M.

Clinical features, diagnosis and treatment of cutaneous lupus erythematosus
pp. 49-49(1)
Author: Haustein U.F.

Dermatopathology and immunohistology of cutaneous and systemic lupus erythematosus
pp. 49-49(1)
Author: Mooney E.

Subacute cutaneous lupus erythematosus
pp. 49-49(1)
Authors: Mascaro J.M.; Herrero C.; Bielsa I.

Systemetic lupus erythematosus, the dermatological point of view
pp. 50-50(1)
Authors: Parodi A.; Rebora A.

SLE overlap with other connective tissue diseases
pp. 50-50(1)
Authors: Jablonska S.; Blaszczyk M.; Chorzelski T.

Skin diseases first described by Japanese dermatologists
pp. 50-50(1)
Author: Miyachi Y.

The nose in tropical dermatology
pp. 50-50(1)
Author: Pradinaud R.

The effects of the ozone depletion in Chile
pp. 50-51(2)
Authors: Honeyman J.F.; Antoine J.L.

Sydney - Australia -- 1997 19th World Congress of Dermatology
pp. 51-51(1)
Author: Cooper A.

International dermatology
pp. 51-51(1)
Author: Ryant T.J.

The clinical contribution to reverse genetics
pp. 53-53(1)
Author: Munro C.

Molecular understanding of lamellar ichthyosis
pp. 54-54(1)
Authors: Hohl D.; Rettler I.; Bernasconi K.; Frenk E.; Lavrijsen A.; Ponec M.; Bon A.; Lautenschlager S.; Schorderet D.; Huber M.

Autosomal recessive lamellar ichthyosis: identification of a new mutation in transglutaminase 1 and evidence for genetic heterogeneity
pp. 54-54(1)
Authors: Parmentier L.; Blanchet-Bardon C.; Nguyen S.; Prud'homme J.-F.; Debertret L.; Weissenbach J.

Phenotype-genotype correlation in bullous ichthyosis
pp. 54-54(1)
Authors: Steijlen M.; Bichakjian C.K.; Melchers D.; Lavrijsen A.P.M.; Kremer H.

Molecular basis of neurofibromatosis type 1 in France: identification and characterization of mutations in the NF1 gene
pp. 54-54(1)
Author: Vidaud D.

Keratin 2e mutations in patients with ichthyosis bullosa of Siemens
pp. 55-55(1)
Authors: Traupe H.; Rothnagel J.A.; Wojcik S.; Huber M.; Hohl D.; Pittelkow M.R.; Saeki H.; Ishibashi Y.; Roop D.R.

How skin diseases can threaten life
pp. 55-55(1)
Author: Roujeau J.C.

Emergencies in dermatology: Stevens-Johnson syndrome and toxic epidermal necrolysis
pp. 55-55(1)
Authors: Schopf E.; Mockenhaupt M.

Necrotizing fascitis
pp. 55-55(1)
Author: Chosidow O.

Choice of format
pp. 55-55(1)
Author: Parish L.C.

Five mistakes an author should never make
pp. 55-55(1)
Author: Freedman D.

How to write and publish a scientific paper
pp. 55-55(1)
Author: Dobson R.L.

How to write and publish a scientific paper. Closing remarks
pp. 56-56(1)
Author: Lotti T.M.

General positioning of topical corticosteroids: classifications, formulations, and overview of indications
pp. 56-56(1)
Author: De Boulle K.

Local side effects of topically applied corticosteroids
pp. 56-56(1)
Author: Habbema L.

Contact allergy for topical steroids: facts and future
pp. 56-56(1)
Author: Dooms-Goossens A.

Ultrasound follow up of steroid treatment
pp. 56-57(2)
Author: Korting H.C.

Systemic side effects of topical corticosteroids: how to recognise them in time. How to limit or avoid them
pp. 57-57(1)
Authors: Tennstedt D.; Lachapelle J.M.

Techniques & indications for micrographic (Mohs') surgery
pp. 57-57(1)
Author: Walker N.P.J.

Is there biological evidence in behavioural difference. Between simple bcc versus recurrent bcc's
pp. 57-57(1)
Author: Neumann H.A.M.

The Mohs laboratory
pp. 57-58(2)
Authors: Umbert P.; Garces J.R.

The importance of Mohs surgery in the treatment of skin tumors localized in a critical sites
pp. 58-58(1)
Authors: Rusciani L.; Carlesimo F.

Mohs micrographic surgery and reconstruction
pp. 58-58(1)
Author: Camps-Fresneda A.

Reconstruction after Mohs surgey. Principles and practice
pp. 58-58(1)
Author: Picoto A.

Mohs -- a Belgian experience
pp. 58-58(1)
Authors: Roseeuw D.; Winnock T.; De Coninck A.; Dierickx P.

Epiluminescence microscopy: introduction
pp. 58-58(1)
Author: Wolff K.

Anatomical analysis of black dots and brown globules
pp. 58-59(2)
Authors: Guillod J.F.; Skaria A.A.; Salomon D.; Saurat J.H.

The ABCD rule of dermatoscopy: high negative predictive value for the recognition of malignant melanomas
pp. 59-59(1)
Author: Stolz W.

Digital image analysis of pigmented skin lesions
pp. 59-59(1)
Author: Binder M.

A practical approach to epiluminescence microscopy
pp. 59-59(1)
Authors: Kenet R.O.; Kenet B.J.; Fitzpatrick T.B.

Is epiluminescence microscopy useful for clinical practice?
pp. 59-59(1)
Authors: Pehamberger H.; Binder M.

Epidermal wound healing, leg ulcers, lichen simplex & psoriasis as models of cytokine behaviour
pp. 60-60(1)
Author: Ryan T.J.

Extra cellular matrix molecules (ECM) and wound healing
pp. 60-60(1)
Author: Westerhof W.

Clinical trials with topically applied growth factors in wound healing
pp. 60-60(1)
Author: Degreef H.

The vascular endothelium as a target of immunological reactions
pp. 60-60(1)
Authors: Sepp N.; Fritsch P.

Cutaneous and systemic vasculitides -- clinical features and classification
pp. 60-60(1)
Author: Fritsch P.

Causative factors of the vasculitis spectrum. Our current knowledge
pp. 60-60(1)
Author: Tosca A.D.

The aetiologic diagnosis of vasculitis
pp. 60-61(2)
Author: Lotti T.M.

Treatment of vasculitis: an overview
pp. 61-61(1)
Author: Claudy A.

Clinical aspects of Kaposi's sarcoma and local treatment modalities
pp. 62-62(1)
Author: Hulsebosch H.J.

Treatment of localized KS lesions
pp. 62-63(2)
Author: Delescluse J.

Strategies for the management of disseminated Kaposi's sarcoma
pp. 63-63(1)
Author: Brambilla L.

Cellulitis. Introduction: attempt of definition
pp. 63-63(1)
Author: De Dobbeleer G.

Erysipelas. Epidemiology, bacteriology and treatment: current concepts
pp. 63-63(1)
Author: Bernard P.

Necrotizing fasciitis (NF): clinical aspects. Four years experience in the area of Brussels
pp. 63-63(1)
Authors: Parent D.; Simonart T.

Necrotizing fasciitis and toxic complications of streptococcal infection: bacteriology and epidemiology
pp. 63-63(1)
Author: Struelens M.J.

Surgical treatment of extensive soft tissue infections
pp. 64-64(1)
Authors: Van Geertruyden J.P.; de Fontaine S.; Goldschmidt D.

Anatomy, physiology and microbiology of the vulva and the vagina
pp. 64-64(1)
Author: Elsner P.

The management of anaerobic (bacterial) vaginosis: past, present & future
pp. 64-64(1)
Author: Blackwell A.

Vulvodynia
pp. 64-64(1)
Author: Ridley C.M.

Dermatological findings in HIV-infected patients from nine European countries
pp. 64-64(1)
Author: Ranki A.

Drug eruptions in HIV-infected patients
pp. 65-65(1)
Authors: Thoma-Greber E.; Hoegl L.; Meurer M.; Rocken M.

Bacterial and protozoal infections in HIV-infected patients
pp. 65-65(1)
Author: Dauden E.

Some viral infections in HIV-infected patients
pp. 65-65(1)
Authors: Cusini M.; Alessi E.

Pruritic skin conditions in HIV infection
pp. 65-65(1)
Author: Hulsebosch H.J.

Oral lesions in HIV-infected patients
pp. 65-65(1)
Authors: Meigel W.; Ramsauer J.; Plettenberg A.

Interferon treatment of HPV infections
pp. 65-66(2)
Author: Gross G.

Clinical application of interferon in cutaneous melanoma
pp. 66-66(1)
Author: Belli F.

Interferons in lupus erythematosus
pp. 66-66(1)
Authors: Nicolas J.F.; Ghohestani R.

Circulating IFN-neutralising immunoglobulins to IFN-alpha in patients with cutaneous T-cell lymphoma
pp. 66-66(1)
Authors: Vejlsgaard G.L.; Ross C.; Tingsgaard P.; Thomsen K.

Current management of genital herpes
pp. 66-67(2)
Author: Petzoldt D.

Surgical and medical treatment of HPV infections
pp. 67-67(1)
Author: Gross G.

Vaccines for HPV and HSV
pp. 67-67(1)
Author: Lacey C.J.N.

Cytokines
pp. 67-67(1)
Author: Bos J.D.

Cytokines in atopic eczema
pp. 67-68(2)
Author: Krutmann J.

Cytokines in wound healing
pp. 68-68(1)
Authors: Lapiere C.M.; Nusgens B.V.

Cytokines in therapy
pp. 68-68(1)
Author: Luger T.

The skin in spondylarthropathies
pp. 69-69(1)
Authors: Veys E.M.; Mielants H.

Overlap and relationship between discoid lupus erythematosus and systemic lupus erythematosus
pp. 69-69(1)
Author: Golstein M.A.

SAPHO syndrome
pp. 69-70(2)
Author: Kahn M.F.

Biopharmaceutical aspects of the formulation of dermatological vehicles
pp. 70-70(1)
Authors: Delattre L.; Delneuville I.

Targetting: how to direct the drug disease
pp. 70-70(1)
Author: Schaefer H.

Factor XIIIa and calprotectin expressivity in cutaneous graft-versus-host reaction developing despite preventive, therapy
pp. 71-71(1)
Authors: Dezfoulian B.; Nikkels-Tassoudji N.; Nikkels A.F.; Pierard-Franchimont C.; Pierard G.E.

Topical photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic keratoses: a first clinical study
pp. 71-71(1)
Authors: Szemies R.M.; Karrer S.; Landthaler M.; Sauerwald A.

A quantitative assessment of basal cell changes in acute graft-vs-host disease
pp. 71-71(1)
Authors: Noto G.; Pravata G.; Arico M.

Generalized sclerodermiform type of chronic graft-versus-host disease
pp. 71-72(2)
Authors: Penas P.F.; Jones-Caballero M.; Aragues M.; Garcia-Diez A.; Fraga J.

Ultrapulse CO2 laser resurfacing
pp. 72-72(1)
Author: Gasiorowski M.E.

Treatment of port-wine stains in small children flashlamp-pumped pulsed dye laser. How should the treatment be organized?
pp. 72-72(1)
Authors: Mork N.-J.; Austad J.; Helsing P.; Kasbohm E.

Angiolymphoid hyperplasia with eosinophilia treatment with laser Nd-YAG
pp. 72-72(1)
Authors: Neves F.; Figueiredo A.; Freitas J.D.; Masson P.; Baptista A.P.; Neves F.

Endermology, a revolutionar technique allowing the defibrosis of the non-infectious cellulitis (or dermo edemato-fibro-sclero-panniculopathy)
pp. 72-72(1)
Authors: Dubois F.; Schuler P.; El-Ali J.

Painless anesthesia via iontophoresis
pp. 73-73(1)
Author: Maloney J.M.

Compression therapy in painful piezogenic pedal papules
pp. 73-73(1)
Authors: Boni R.; Dummer R.

Three cases of parvovirus B19 positive ''gloves and socks'' syndrome
pp. 73-73(1)
Authors: Rivara G.; Grazi G.; Farris A.

Maternal-foetal transmission of human papillomavirus infection
pp. 73-73(1)
Authors: Fimiani M.; Mazzatenta C.; Buffi C.; Messina G.; Biagioli M.

Limiting the continued spread of genital herpes
pp. 73-74(2)
Author: Kroon S.

Treatment of first episode genital herpes with famciclovir
pp. 74-74(1)
Authors: Harris J.R.W.; Sacks S.L.

Famciclovir: long-term safety in recurrent genital herpes treatment
pp. 74-74(1)
Author: Boon R.

Episodic clinic- and patient-initiated famciclovir (FCV) for recurrent genital herpes (GHSV): a combined analysis.
pp. 74-74(1)
Author: Sacks S.L.

Astemizole -- an alternative of classical antiinflammatory drugs in Herpes zoster
pp. 74-74(1)
Author: Iankova R.

A randomized, controlled trial of acyclovir versus netivudine for treatment of Herpes zoster
pp. 74-75(2)
Authors: Soltz-Szots J.; Lucht R.F.; Fiddian A.P.

Economic evaluation of the impact of antiviral therapy on shingles
pp. 75-75(1)
Authors: Nathwani D.; Holt S.d.-P.; Davey P.G.

The clinical efficacy of valaciclovir in the treatment of Herpes zoster
pp. 75-75(1)
Authors: Johnson R.W.; Crooks R.J.

Treatment of condylomata acuminata with intralesional AccuSite^TM (fluorouracil/epinephrine) injectable gel: a phase III study
pp. 75-75(1)
Authors: Swinehart J.; Sperling M.; Phillips S.; Kraus S.; Gordon S.; Orenberg E.K.

The vulval clinic -- how is it used?
pp. 75-75(1)
Authors: Stewart E.; Wojnarowska F.

Evaluation of physician practices in counselling patients with sexually transmitted diseases (STDs)
pp. 76-76(1)
Author: Wysocki S.

Sexually transmitted diseases: 1st edition of guidelines for diagnosis & therapy in Holland
pp. 76-76(1)
Authors: Van Voorst Vader P.C.; Henquet C.J.M.; Blog F.B.; de Wit R.F.E.; Stolz E.; Bleker O.P.; Tillemans G.J.

Social-individual characteristics of patients with syphilis
pp. 76-76(1)
Author: Korobeinikova E.A.

Prevalence of hepatitis B and C in the family planning center of Nancy
pp. 76-76(1)
Authors: Le Faou A.; Goudot E.; Catelle A.; Pontus J.

Chlamydial infection in pregnants
pp. 76-77(2)
Authors: Merslakov V.A.; Belashova I.M.; Shinsky G.E.

Chlamydial infection in children
pp. 77-77(1)
Authors: Shinsky G.E.; Bychkova N.Y.; Grossman E.Y.

Combined treatment of vaginitis caused by chlamydia trachomatis by Rulid (Roussel) and dosed local hyperthermia method
pp. 77-77(1)
Authors: Sluzhinska O.; Sluzhinska M.

OPC-17116 in the treatment of gonococcal and chlamydial cervicitis
pp. 77-77(1)
Authors: Mroczkowski T.F.; Martin D.H.; Bean K.A.; Maroli A.N.

Intralesional cyclosporine versus anthralin in plaque-type psoriasis
pp. 77-77(1)
Authors: Petronic-Rosic V.; Milojevic M.; Cvijetic O.; Marinkovic J.

Cyclosporine -- a in psoriatic arthritis: 4 years of experience
pp. 77-78(2)
Authors: Garcovich A.; Pompili A.; Gatti M.; Catamo F.; Alotto M.; Olivetti G.

Pharmacokinetics and tolerability of a new formulation of cyclosporin A in de novo treated psoriatic patients
pp. 78-78(1)
Authors: Finzi A.; Ippolito F.; Mozzanica N.; Schmitt E.; Carducci M.; Leoni L.; Casa-Alberighi O.D.

Systemic tacrolimus (FK506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study
pp. 78-78(1)
Author: Ruzicka T.

Efficacy and safety of a new oral formulation of cyclosporin in treatment of psoriasis
pp. 78-79(2)
Authors: Munro C.; Rogers S.; Chalmers R.; Norris P.; Friedmann P.; Dowd P.; Graham-Brown R.; Marks R.; Berth-Jones J.; Sumner M.

Evaluation of maintenance regimens in psoriatic patients after remission with cyclosporin
pp. 79-79(1)
Authors: Nakagawa H.; Ishibashi Y.; Ohkawara A.; Tagami H.; Harada S.; Ohkido M.; Imamura S.; Yoshikawa K.; Hori Y.

Erythrodermic psoriasis associated with mycosis fungoides -- letal evolution under treatment with cyclosporin and etretinate
pp. 79-79(1)
Authors: Nedelcu I.; Marinescu V.

Phaeohyphomycosis caused by alternaria species and Phaeosclera dematioides
pp. 79-79(1)
Authors: Pec J.; Palencarova E.; Jesenska J.; Plank L.; Straka S.; Filo V.; Hajtman A.

A multicentric, double-blind parallel group study comparing the efficacy, safety and tolerability of terbinafine (250 mg/day) with griseofulvin (1 g/day) in the treatment of dermatophytic onychomycosis
pp. 79-79(1)
Author: Baran R.

Randomized double-blind multicentre study of efficacy & tolerability of terbinafine for 1, 2 and 4 weeks in the treatment of tinea capitis
pp. 79-80(2)
Authors: Haroon T.S.; Hussain I.; Aman S.; Jahangir M.; Kazmi A.H.; Sami A.R.; Alvi K.H.; Iqbal N.; Khan K.A.

Double-blind study with itraconazole in the treatment of onychomycosis
pp. 80-80(1)
Authors: Baudraz-Rosselet F.; Morier P.; Perroud H.M.; Ramelet A.-A.; Ruffieux C.; Tapernoux B.

Fifteen-day itraconazole regimen in recalcitrant forms of tinea
pp. 80-80(1)
Authors: Savova J.; Iankova R.; Zisova L.; Iankova R.

One week treatment with local terbinafine cream (Lamisil) has the same clinical efficacy as four weeks treatment with local miconazol cream (Daktarin)
pp. 80-80(1)
Authors: Vermeer B.J.; Staats C.C.G.; van Houwelingen J.C.

Impact of ketoconazole on fungal skin infections in renal transplant recipeints receiving cyclosporine
pp. 80-80(1)
Authors: Abdel-Hamid I.A.; Sobh M.; Elagroudy A.; Eid M.; El Mogy M.; Elsawy E.; Ghoneim M.

Electrophoretic protein profile of dermatophytes and its correlation with specific IgE in acute and chronic dermatophytosis
pp. 81-81(1)
Authors: Al-Sogair S.M.; Rahi A.H.; Moawad M.K.; Hay R.J.

Double-blind randomised study: once daily flutrimazole 1% solution vs. bifonazole 1% solution in dermatomycoses
pp. 81-81(1)
Authors: del Palacio A.; Cuetara S.; Lopez S.; Iglesias L.; Izquierdo I.; Videla S.; Forn J.

Efficacy and tolerance of econazole with liposomes in the treatment for tinea corporis/cruris and tinea pedis. Polish multicenter study
pp. 81-81(1)
Authors: Szepietowski J.; Baran E.; Maj J.; Wasik F.; Wilkowska A.; Szarmach H.; Czubek M.; Szarmach A.; Siedlewicz A.; Adamski Z.; Bowszye J.; Choczaj K.; Burzynska B.

Familial benign pemphigus: a trichophytosis form
pp. 81-81(1)
Author: Chevallier J.M.

Demonstration of antibodies to bovine desmocollin isoforms in pemphigus sera
pp. 81-81(1)
Authors: Dmochowski M.; Hashimoto T.; Chidgey M.A.J.; Yue K.K.M.; Wilkinson R.W.; Nishikawa T.; Garrod D.R.

Steroid treatment in children with erythema multiforme major
pp. 82-82(1)
Authors: Kakourou T.; Klontza D.; Soteropoulou F.; Kattamis C.

Junctional epidermolysis bullosa and pyloric atresia: clinical and pathological studies in five patients
pp. 82-82(1)
Authors: Valari M.D.; Harper J.I.; Lake B.D.

Porphyria in Ireland
pp. 82-82(1)
Authors: O'Reilly F.M.; Darby C.; O'Moore R.; Murphy G.M.

Hepatitis C virus (HCV) in porphyria cutanea tarda (PCT)
pp. 82-82(1)
Authors: Cribier B.; Petiau P.; Keller F.; Schmitt C.; Heid E.; Grosshans E.

Porphyrin urinary excretion profile in hepatitis C virus (HCV) and HIV infected patients
pp. 83-83(1)
Authors: Cribier B.; Rey D.; Le Coz C.; Uhl G.; Hirth C.; Grosshans E.

Should patients with normal bowel biopsies follow a gluten-free diet?
pp. 83-83(1)
Authors: Buckley D.; McDermott R.; O'Donoghue D.; Rogers S.

Anamnese, anamnese
pp. 83-83(1)
Authors: Aitken G.; Delanoe J.; Deverge G.; Gabeff M.; Jaud P.; Lorent A.; Mugnier P.; Sei J.F.; Serny R.; Vignali J.P.

Dermatology inpatient admission improves quality of life
pp. 83-83(1)
Authors: Kurwa H.A.; Finlay A.Y.

Skin disease in general practice
pp. 83-83(1)
Author: Selvaag E.

Erosive vulval lichen planus: a clinico pathological study
pp. 83-84(2)
Authors: Wakelin S.H.; Wojnarowska F.

Successful treatment of erosive bullous oral lichen planus with cyclosporin-A
pp. 84-84(1)
Author: Torok L.

Hepatitis C viremia in erosive and classic lichen planus
pp. 84-84(1)
Authors: Schmitt E.C.; Mozzanica N.; Finzi A.F.; Tagger A.; Ribero M.L.; Del Ninno E.; Parravicini M.L.

An immunohistological study of rosacea, and the effect of metronidazole on the disease process
pp. 84-84(1)
Authors: Scerri L.; Edgar D.; Saihan E.; Sewel H.

Lichen planus and hepatitis C
pp. 84-85(2)
Authors: Gimenez-Arnau A.; Alayon-Lopez C.; Camarasa J.G.

Systemic effect of magnetic fields on the lymphatic system
pp. 85-85(1)
Authors: Dubois F.; Peuvot J.; Schuler P.; Burtin B.; Flamand J.P.; Hanson B.; Jacques Y.; Puttemans N.; Struelens M.; Verhas M.; Borel C.

Contribution of isotopic lymphography to the diagnosis of vascular insufficiency of lower limbs. Preliminary analysis of 92 patients
pp. 85-85(1)
Authors: Dubois F.; Schuler P.; Jacques Y.; Puttemans N.; Verhas M.; Flamand J.P.

Catamnesis of the lichen planus
pp. 85-85(1)
Authors: Bragina O.M.; Nikitina L.S.; Shinsky G.E.

Treatment of toxic pustuloderma with acitretin a clinical observation
pp. 85-85(1)
Authors: Courvoisier S.; Itin P.; Fluckiger R.

Sarcoma idiopaticum multiplex haemorhagicum Kaposi -- interferon-alpha-2b-therapy
pp. 86-86(1)
Authors: Navratilova Z.; Semradova V.

Porphyria cutanea tarda to cyproterone acetate: first case report
pp. 86-86(1)
Authors: Lambert D.; Boulitrop C.; Ferenczi F.; Dalac S.

The Component Skin Equivalent(R) - a new method for healing superficial and deep wounds
pp. 86-86(1)
Authors: Ruszczak Z.; Stadler R.

Etretinate concentrations in plasma and subcutis of acitretin-treated female patients
pp. 86-86(1)
Authors: Wiegand U.-W.; De Bersaques J.; de la Brassinne M.; Hoenigsmann H.; Jansen C.; Marks R.; Salomon D.; Wyss R.

Treatment of seborrhoeic dermatitis of the scalp with lamisil (terbinafine) 1% solution: a pilot study
pp. 86-87(2)
Author: Fergemann J.

Cyclosporin A in cutaneous vasculitis and pyoderma gangraenosum
pp. 87-87(1)
Author: Zachariae H.

Cutaneous Crohn's disease responsive to cyclosporin A
pp. 87-87(1)
Authors: Bardazzi F.; Neri I.; Tosti A.; Guidetti M.S.

A case of eosinophilic fasciitis which can only be treated by cyclosporin-A
pp. 87-87(1)
Authors: Atmanoglu N.; Uslu F.; Gulcan P.; Arda K.; Ogreten O.

Clinical and immunologic aspects of staphylodermas pathogenesis
pp. 87-87(1)
Authors: Katkhanov A.M.; Tlish M.M.

HLA-DR₂ segregation in leprosy
pp. 87-88(2)
Author: Dessoukey M.W.

Cutaneous infections due to mycobacteria
pp. 88-88(1)
Authors: Lilie H.M.; Staedt S.W.W.

Detection of borreliae in the placenta of two patients with erythema migrans
pp. 88-88(1)
Authors: Hercogova J.; Zivny J.; Janovska D.; Hulinska D.

Microbiology of hidradenitis suppurativa
pp. 88-88(1)
Authors: Jemec G.B.E.; Faber M.; Gutschick E.; Wendelboe P.

cutaneous leishmaniasis in Yemen
pp. 88-88(1)
Authors: Al Salami S.F.; Molan A.L.

Cutaneous leishmaniasis in the Maltese Islands
pp. 88-88(1)
Author: Pace J.L.

Cutaneous leishmaniasis
pp. 89-89(1)
Authors: El Shamy S.I.; El Mogy M.H.

Ciclosporin A in atopic dermatitis: preliminary results with a new galenical formulation
pp. 89-89(1)
Authors: Kagi M.K.; Kleinman M.; Zurbriggen B.; Burg G.; Wuthrich B.

Cyclosporine A microemulsion in severe atopic dermatitis
pp. 89-89(1)
Authors: Gonzalez F.; Donelli E.; Sanz A.

Short-term cyclosporin in severe childhood eczema
pp. 89-89(1)
Authors: Salek S.; Zaki I.; Tan B.; Goodyear H.; Lewis-Jones S.; Cork M.; Graham-Brown R.; Finlay A.; Allen R.; Friedmann P.; Harper J.; Bleehen S.; Camp R.; Berth-Jones J.; Smith S.

Effect of cyclosporin on quality of life in severe childhood eczema
pp. 89-90(2)
Authors: Finlay A.Y.; Berth-Jones J.; Zaki I.; Tan B.; Goodyear H.; Lewis-Jones S.; Cork M.; Graham-Brown R.; Allen R.; Friedmann P.; Harper J.; Bleehen S.; Camp R.; Salek M.S.; Smith S.

Azathioprine in severe adult atopic eczema
pp. 90-90(1)
Authors: Buckley D.; Baldwin P.; Rogers S.

Abscessed inflammation as a serious complication of low dose cyclosporin A in atopic dermatitis
pp. 90-90(1)
Authors: Boni R.; Dummer R.

Pathophysiology of photosensitivity to piroxicam
pp. 90-90(1)
Authors: Figueiredo A.; Goncalo M.; Tavares P.; Ribeiro C.A.F.; Teixeira F.; Baptista A.P.

Photosensitivity to piroxicam. Clinical aspects
pp. 90-91(2)
Authors: Goncalo M.; Figueiredo A.; Baptista A.P.

Aspergillosis of the maxillary sinus and urticaria
pp. 91-91(1)
Author: Leport Y.

Subpharmacological concentrations of retinoic acid attenuate the antiproliferative effect of calcitriol on cultured human keratinocytes
pp. 91-91(1)
Authors: Segaert S.; Garmyn M.; Bouillon R.; Degreef H.

Skin absorption of ³H-calcitriol after dermal application
pp. 91-91(1)
Authors: van Harten J.; Mathlener I.S.

Topical calcitriol for the treatment of facial, hairline and retroauricular psoriasis
pp. 91-91(1)
Author: de la Brassinne M.

Comparison of calcitriol ointment plus corticosteroid ointment with corticosteroid alone in chronic plaque psoriasis
pp. 92-92(1)
Authors: Claro C.; Melo H.; Soares A.P.

Long-term safety and tolerability of topical calcitriol in chronic plaque psoriasis
pp. 92-92(1)
Author: Langner A.

Calcipotriol cream and betamethasone valerate cream of equal efficacy in psoriasis
pp. 92-92(1)
Authors: Molin L.; Cutler T.P.; Helander I.; Nyfors B.

Clinical and immunological evaluation of combination therapy (narrow band UVB, dithranol, calcipotriol) in psoriasis patients
pp. 92-92(1)
Authors: De Rie M.A.; Bos J.D.

Calcipotriol versus coal tar in Mexican patients with psoriasis
pp. 92-92(1)
Authors: Arevalo A.; Vega-Lopez F.

The calcipotriol (PSOCUTAN^DC) associated with PUVA + UVB in the treatment of psoriasis
pp. 93-93(1)
Authors: Nedelcu I.; Nedelcu D.-M.

Chronic generalized dermatophytosis
pp. 93-93(1)
Authors: Boudghene-Stambouli O.; Meradboudia A.

Interest of the combination of 5% amorolfine nail lacquer + terbinafine tablet in the treatment of foot dermatophyte onychomycosis with involved matrix
pp. 93-93(1)
Authors: Feuilhade M.; Baran R.; Goettmann S.; Pietrini P.; Viguie C.; Larnier C.; Badillet G.

A double-blind comparison of levels of terbinafine and itraconazole in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and toe nails during and after 250 mg terbinafine or 200 mg itraconazole orally once daily for 28 days
pp. 93-93(1)
Authors: Faergemann J.; Zehender H.; Boukhabza A.; Smith S.G.; Jones T.C.

A double-blind multicentre trial of 1% terbinafine cream (1 wk) vs 1% clotrimazole cream (4 wks) in tinea pedis
pp. 94-94(1)
Authors: Barnetson R.S.; Marley J.; Bullen M.; Brookman S.; Ellis D.; Johnson T.

Comparison of terbinafine levels in stratum corneum and dermis-epidermis (without stratum corneum) after topical or topical combined with oral therapy in healthy volunteers
pp. 94-94(1)
Authors: Faergemann J.; Zehender H.; Boukhabza A.; Ganslandt J.; Jones T.C.

Efficacy of batrafen (ciclopiroxolamine) in treatment of dermatomycose. An open multicenter study, Poland
pp. 94-94(1)
Authors: Cislo M.; Baran E.; Walow B.; Adamski Z.; Bowszyc J.; Kadziela-Wypyska G.; Lecewicz-Torun B.; Wilkowska A.; Czubek M.; Szarmach H.; Nierebinska E.; Urbanowski S.; Gwiezdzinski Z.; Broniarczyk-Dyla C.; Arkuszewska C.; Krajewska-Kulak E.; Poniecka H.; Chodynicka B.

Itraconazole in the treatment of chronic mucocutaneous candidiasis in childhood
pp. 94-94(1)
Authors: Piraccini B.M.; Vincenzi C.; Cameli N.; Tosti A.

Treatment of tinea pedis with lamisil
pp. 94-95(2)
Authors: Vladimirov V.; Kuryanova O.; Menshikova L.; Cheremuchina I.

A 12 weeks treatment for dermatophyte toe-onychomycosis: terbinafine 250 mg/d or itraconazole 200 mg/d? A double blind comparative trial
pp. 95-95(1)
Authors: De Backer M.; van Lierde M.A.; De Keyser P.; Do Vroey C.; Lesaffre E.

Double-blind, parallel group comparison of fluconazole 150 mg once weekly and griseofulvin 500 mg once daily for 6 weeks in the treatment of tinea corporis or tinea cruris
pp. 95-95(1)
Authors: Faergemann J.; Mork N.J.; Haglund A.; Odegard T.

Minocycline is a useful adjuvant therapy for pemphigus
pp. 95-95(1)
Authors: Gaspar Z.S.; Walkden V.; Wojnarowska F.

Neonatal lupus erythematosus
pp. 95-96(2)
Authors: Ruas E.; Moreno A.; Tellechea O.; Baptista A.P.

Cicatricial pemphigoid: a dual circulating antibody response with IgG and IgA correlates with a more severe and persistent disease
pp. 96-96(1)
Authors: Setterfield J.; Bhogal B.; Morgan P.; Shirlaw P.; Kerr-Muir M.; Challacombe S.; Black M.M.

Pemphigoid presenting as atypical pruritic eruption
pp. 96-96(1)
Authors: Gengoux P.; Lachapelle J.M.

Hair involvement in lupus erythematosus chronicus discoides
pp. 96-96(1)
Authors: Pramatarov K.; Obreshkova E.

Direct immunofluorescence findings in dermatomyositis
pp. 96-97(2)
Authors: Jones S.A.V.; Bhogal B.S.; Black M.M.

Cutaneous polyarteritis nodosa in a child
pp. 97-97(1)
Authors: Torrelo A.; Navarro L.; Mediero I.G.; Zambrano A.

Pyoderma gangrenosum and its subsets
pp. 97-97(1)
Author: Dourmishev A.L.

Pyoderma gangrenosum -- a study of 34 cases
pp. 97-97(1)
Authors: von den Driesch P.; Huner A.

Is organ-specific autoimmunity a risk for vitiligo?
pp. 97-97(1)
Authors: Frati C.; Martone F.R.; Amendo-Lea M.A.; Persichino S.; Masala C.

Italian multicenter study of allergic contact photodermatitis: epidemiological aspects
pp. 97-98(2)
Authors: GIRDCA group; Pigatto P.D.; Legori A.; Bigardi A.S.

Occupational blepharoconjunctivitis and contact dermatitis caused by gold
pp. 98-98(1)
Authors: Estlander T.; Kanerva L.; Jolanki R.; Kari O.

Epoxy allergy updated
pp. 98-98(1)
Authors: Jolanki R.; Kanerva L.; Estlander T.

Contact allergy to ethoxylated alkylphenols
pp. 98-98(1)
Author: Reuter G.

Contact allergy to dexpanthenol
pp. 98-98(1)
Authors: Schmid-Grendelmeier P.; Wyss M.; Elsner P.

Sensitization to occupational allergens during apprenticeship at hairdressing school
pp. 99-99(1)
Authors: Petronic-Rosic V.; Gajic M.; Milojevic M.

Changing epidemiologic characteristics of melanoma: 1978-1994
pp. 99-99(1)
Authors: de las Heras M.E.; Marques A.; Ledo E.; Nunez M.; Rocamora A.; Ledo A.

HLA antigens in atypical mole syndrome and malignant melanoma
pp. 99-99(1)
Authors: Porto M.T.; Amaro J.; Pecegueiro M.; Lopes M.J.; Branco H.; Martins B.

Profile of people attending melanoma screening clinics in the Netherlands
pp. 99-99(1)
Authors: de Rooij M.J.M.; Rampen F.H.J.; Schouten L.J.; Neumann H.A.M.

Prevalence of melanocytic naevi in a population of Turkish school children: anatomic distribution and correlation with phenotype
pp. 99-100(2)
Authors: Yucelten D.; Ergun T.; Gurbuz O.; Bekiroglu N.

IFN-alpha and 13-cis-retinoic acid in the treatment of metastatic melanoma -- a comparison of two phase H studies
pp. 100-100(1)
Authors: Fierlbeck G.; Schreiner T.; Blessing C.

Satellitosis from melanoma: local treatment with electrosurgery
pp. 100-100(1)
Authors: Marsden J.R.; Lewis H.M.

Metastatic melanoma: staging with whole body positron-emission tomography (PET) and first experience with imagefusion PET-spiral- computed-tomography
pp. 100-100(1)
Authors: Boni R.; Steinert H.; Huch Boni R.A.; Berthold T.; Dummer R.; Burg G.; von Schulthess G.K.

Lentigo maligna: surgical treatment
pp. 100-101(2)
Authors: Marsden J.R.; Sanders D.S.A.

Radioiodine-labeled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and first results with patients
pp. 101-101(1)
Authors: Boni R.; Steinert H.; Boni R.H.; Meyer J.; Dummer R.; Muletta S.; Burg G.; Westera G.

Comparison of whole-body dopamine-D-2 receptor ligand scintigraphy and whole-body anti-melanoma antibody-fragment scintigraphy in the staging of malignant melanoma
pp. 101-101(1)
Authors: Boni R.; Steinert H.; Boni R.A.H.; Dummer R.; Burg G.; Berthold T.; von Schulthess G.K.

Clinical and morphological investigation in etiology of atopic dermatitis
pp. 101-101(1)
Authors: Krakope A.; Zalcmane V.

Family impact of childhood atopic eczema
pp. 101-101(1)
Authors: Lawson V.; Lewis-Jones M.S.; Reid P.; Owens R.G.; Finlay A.Y.

Allergen inhalation challenge causes flare of atopic dermatitis
pp. 101-102(2)
Authors: Brinkman L.; Langeveld-Wildschut E.G.; Koenderman L.; Lammers J.-W.J.; Bruijnzeel-Koomen C.A.F.M.

Comparison between the atopy patch test and the late phase reaction in atopic eczema patients
pp. 102-102(1)
Authors: Langeveld-Wildschut E.G.; Thepen T.; Bihari I.; Bruijnzeel P.L.B.; Bruijnzeel-Koomen C.A.F.M.

Sweating response to physical exercise in patients with atopic eczema
pp. 102-102(1)
Authors: Strickling U.; Schuch S.; Hornstein O.P.; Salzer B.

Dependence of skin lesion topography in atopic dermatitis on segmentary vertebral disfunction
pp. 102-102(1)
Authors: Toropova N.P.; Mazheiko L.I.; Talantsev A.F.

Atopic dermatitis and lambliasis in children: mechanisms of skin pathology and pruritis
pp. 102-103(2)
Authors: Toropova N.P.; Gradinarov A.M.; Sofronova N.A.

IgE antibodies to protein and mannan antigens of Pityrosporum ovale in atopic dermatitis patients
pp. 103-103(1)
Authors: Lintu P.; Savolainen J.; Kalimo K.

Atopic dermatitis in food allergic children
pp. 103-103(1)
Authors: Farhoudi A.; Pourpak Z.; Yazdani F.; Motamedi F.

Blood flow in neurogenic erythema is altered in atopic dermatitis
pp. 103-103(1)
Authors: Glinski W.; Pieczara D.; Bachurzewska B.

Renal function in patients with psoriasis
pp. 103-103(1)
Authors: Podoswa N.; Serrano L.G.; Vega-Lopez F.; Villanueva R.M.; Flores G.; Gordon F.

The peculiarities of hormonal homeostasis disturbance in psoriatic disease
pp. 103-103(1)
Authors: Zagrtdinova R.M.; Shinsky G.E.; Trusov V.V.

Early histopathologic changes in psoriasis
pp. 104-104(1)
Authors: Cerimele D.; La Parola I.L.; Masini C.; Capuano M.; Uccini S.

A noninvasive method for quantification of human neutrophil elastase activity and elastase-inhibiting activity in psoriatic and healthy skin extracts
pp. 104-104(1)
Authors: Stephanek K.; Levy J.J.

Treatment of psoriasis at the Dead Sea in Jordan
pp. 104-104(1)
Authors: Bisharat Z.Z.; Alawi H.

Treatment of scalp psoriasis with 2% ketoconazole shampoo and Psanol(R)
pp. 104-104(1)
Authors: Tsankov N.; Kazandjieva J.; Kamarashev J.; Kadurina M.; Mateev G.; Zisova L.

A randomized, single-blind study to compare hydrocortisone 17-butyrate 0.1% emulsion versus betamethasone 17,21-dipropionate 0.05% lotion in the treatment of patients suffering from psoriasis of the scalp
pp. 104-105(2)
Authors: De Cuyper C.; Degreef H.J.; de la Brassinne M.; Delescluse J.; Derumeaux L.; Heenen M.; Kint A.; Roseeuw D.

Serum levels of interleukin 1, tumour necrosis factor and interferon- in patients with psoriasis vulgaris
pp. 105-105(1)
Authors: Kamel N.A.; Moubasher A.A.; Azeem N.E.A.

Value of cyclosporin in kidney transplanted patients suffering from severe plaque psoriasis
pp. 105-105(1)
Authors: Toronyi E.; Hidvegi M.; Remport A.; Jaray J.; Podder H.; Perner F.

Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological, and immunogenetic study
pp. 105-105(1)
Authors: Kirtschig G.; Chow E.; Venning V.; Wojnarowska F.

Essentiale forte in the treatment of psoriasis patients undergoing thalassotherapy: a double-blind, placebo-controlled study
pp. 105-106(2)
Authors: Kiriakova N.; Gundermann K.-J.; Schneider E.; Ulbrich M.

Skinoren for the treatment of acne
pp. 106-106(1)
Authors: Berova N.; Kiriakova N.; Dourmishev A.; Nikolova A.

New acne grading method using semi quantitative count: ECLA grading
pp. 106-106(1)
Authors: Dreno B.; Humbert P.; Poli F.; Bodock I.; Chivot M.; Daniel F.

Acne keloidica with contact allergy to benzoylperoxide
pp. 106-106(1)
Authors: Schmid-Grendelmeier P.; Spirig W.; Burg G.

Glomus tumor of the nail apparatus clinical and histologic aspect
pp. 106-106(1)
Author: Reuter G.

A conservative technique for the correction of stage 1 and 2 ingrown toenails
pp. 106-107(2)
Authors: Piraccini B.M.; Tosti A.; Giordani M.; Parmeggiani F.

A case of uncombable hair
pp. 107-107(1)
Author: Selvaag E.

Androgenetic alopecia: a new therapeutical approach
pp. 107-107(1)
Authors: Claudatus J.; Bufo P.; d'Ovidio R.

Human hair production by balding scalp grafts maintained onto nude mice is modulated by testosterone
pp. 107-107(1)
Authors: de Brouwer B.; Tetelin C.; Neste D.V.

1,500 grafts using the CO2 Silk Touch Laser, Choi Transplanters and Calvitron Hair Transplant System
pp. 107-108(2)
Author: Kourtis M.

Follow-up study of 500 patients 3 years after surgical implantation of artificial fibres on the scalp
pp. 108-108(1)
Author: D'Ugo A.

Facial multiple cylindromas in twins
pp. 108-108(1)
Authors: Camarasa J.G.; Cucurell M.; Diaz C.; Barranco C.; Gimenez-Arnau A.

KID syndrome and pachydermatoglyphia about two observations
pp. 108-108(1)
Authors: Boudghene-Stambouli O.; Meradboudia A.

Frey's syndrome: three cases
pp. 108-108(1)
Author: Ellena V.

Hyper IgD syndrome presenting as a magic syndrome a 20 year follow-up
pp. 108-108(1)
Authors: Humbert P.; Aubin F.; Desmurs H.; Dupond A.S.; Blanc D.; Buchet S.

Proinflammatory eicosanoids and interleukin-1 in suction blister fluid form primary irritated human skin
pp. 109-109(1)
Authors: Heinzelmann T.; Muller-Decker K.

Expression of MxA protein in inflammatory dermatoses
pp. 109-109(1)
Authors: Fah J.; Pavlovic J.; Burg G.

An appraisal of acitretin treatment in children with inherited disorders of keratinization
pp. 109-109(1)
Authors: Lacour M.; Atherton D.J.; Harper J.I.

Scaling and stratum corneum turnover time
pp. 109-109(1)
Authors: Effendy I.; Chiappe M.; Maibach H.I.

Experimental irritant skin responses to retinoic acid
pp. 110-110(1)
Authors: Effendy I.; Weltfriend S.; Maibach H.I.

Acquired reactive perforating collagenosis
pp. 110-110(1)
Authors: Sass U.; Forton F.; Dequenne I.; Dereume J.L.; Andre J.

Pseudoxanthoma elasticum-like papillary dermal elastolysis. A new case
pp. 110-110(1)
Authors: Vargas-Diez E.; Fernandez-Penas P.; Fraga J.; Aragues M.; Garcia-Diez A.

B-cell clonal population in lymphomatoid papulosis (LyP) lesions
pp. 110-110(1)
Authors: Ortiz-Romero P.L.; Morales P.; Lopez-Estebaranz J.L.; Vanaclocha F.

Two cases of malignant atrophic papulosis (MAP) (Degos' disease)
pp. 110-111(2)
Authors: Noury E.; Dezfoulian B.; Duperrat-Noury G.; Kateb-Lesenechal M.; Bison J.; Delaporte E.; Pierard G.E.; de la Brassinne M.

Sheddon Wilkinson disease: clinical presentation and therapeutic management
pp. 111-111(1)
Authors: Le Maitre M.; Dompmartin A.

Supernumerary nipple and Becker's naevus: a previously undescribed ectomesodermal association. Report of 9 cases
pp. 111-111(1)
Authors: Urbani C.E.; Betti R.

Trigeminal trophic syndrome
pp. 111-111(1)
Authors: Goossens C.; Gheeraert P.; Andre J.; Moerman C.; Song M.

Kaposi's sarcoma ... at the cross-roads of the immune and neuroendocrine systems
pp. 111-112(2)
Author: Thibaut S.

Kaposi's sarcoma in kidney transplant recipients -- immunological studies
pp. 112-112(1)
Authors: Kamal A.M.; Rashid A.

A study on HIV seropositivity in Lagos, Nigeria
pp. 112-112(1)
Authors: Olumide Y.M.; Dada A.J.

Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells
pp. 112-112(1)
Authors: Uccini S.; Baroni C.D.; La Parola I.L.; Masini C.; Cerimele D.

Microinvasive squamous cell carcinoma of the penis in a 25-year-old HIV positive patient
pp. 112-112(1)
Authors: Munoz M.A.; Rodriguez-Pichardo A.; Camacho F.

Changes in the sexual behavior of patients attending a HIV testing center
pp. 112-113(2)
Authors: Cribier B.; Schmitt M.P.; Le Coz C.; Grosshans E.

CD₄ CD₈ and CD₄CD₈ ratio in HIV-infected individuals with and without cutaneous manifestations
pp. 113-113(1)
Authors: Kamal A.M.; Al-Abdulla H.; El-Ebrahim A.M.

Immunogenetic findings in classical Kaposi's sarcoma in Italy
pp. 113-113(1)
Authors: Cerimele D.; Cottoni F.; Carcassi C.; Contu L.

Cutaneous manifestations in 143 immunocompromised children
pp. 113-113(1)
Authors: El Hachem M.; Pianosi G.; Castelli G.G.; Bernardi S.; Greco M.; Rizzoni G.

Protective effects of anti-oxidants on ozone-induced cell lysis in human keratinocyte cultures
pp. 113-113(1)
Authors: Deby C.; Dupont G.; Van Strubarq A.; Roseeuw D.

Current status of the rating of clothing for sun protection
pp. 114-114(1)
Authors: Georgouras K.E.; Stanford D.G.

Experimental reproduction of polymorphic light eruption and benign summer light eruption by whole body UVA-irradiation
pp. 114-114(1)
Authors: Lambert J.; Verheyen A.; Dockx P.

Polymorphic light eruption an immunohistochemical study of provoked lesions
pp. 114-114(1)
Authors: Verheyen A.; Lambert J.; Dockx P.

Phototoxic cell death due to sulphonamide derived oral antidiabetics and diuretics in vitro
pp. 114-114(1)
Authors: Selvaag E.; Anholt H.; Moan J.

The effect of N-acetylcysteine on the UVB-induced early gene response and inhibition of DNA synthesis in human keratinocytes
pp. 114-114(1)
Authors: Garmyn M.; Degreef H.

Histochemical and ultrastructural study of repetitive suberythemal UVA-doses in non-photosensitive patients
pp. 115-115(1)
Authors: Lambert J.; Verheyen A.; Dockx P.

Sunburn cell induction during ultraviolet-B therapy
pp. 115-115(1)
Authors: Dobric I.; Pasic A.; Baricevic B.; Paljan D.; Basta-Juzbasic A.

Evaluation of UV photoprotection using in vivo fluorescence spectroscopy
pp. 115-115(1)
Authors: Utz S.R.; Knuschke P.

Skin optical parameters determination for laser diagnostics and therapy
pp. 115-115(1)
Authors: Utz S.R.; Yaroslavsky I.V.; Sinichkin Y.P.

Tobacco smokers tan more often, believe solar exposure is beneficial, and use less solar protection than nonsmokers
pp. 115-116(2)
Authors: Fleischer A.B.; Feldman S.R.

In office liposuction -- state of the art
pp. 116-116(1)
Author: Gasiorowski M.E.

Skin conditioning before and after a chemical peel
pp. 116-116(1)
Author: Obagi Z.E.

Quality of life impairment before and after treatment of basal cell carcinomas
pp. 116-116(1)
Authors: Blackford S.; Roberts D.L.; Salek M.S.; Finlay A.Y.

The use of modified Mohs surgery in the treatment of skin cancer early results
pp. 116-116(1)
Authors: Bieniek A.; Cislo M.; Wasik F.; Kuniewska B.

Microchart: a new era in micrographic surgery
pp. 116-116(1)
Author: Marini L.

Treatment of basal cell carcinoma with AccuSite^TM (fluororacil/epinephrine) injectable gel results in high cure rates: multicenter phase II study
pp. 117-117(1)
Authors: Shavin J.; Cognetta A.; Buchanan S.; Salasche S.; Taylor J.R.; Gorsulowsky D.; Lowe N.; Orenberg E.

Postsurgical quality control in micrographic surgery
pp. 117-117(1)
Author: Marini L.

Cryosystem: a new, complete device for tissue processing in micrographic surgery
pp. 117-117(1)
Author: Marini L.

Transpleural neurotomy in cases of severe hyperhidrosis of the hands or the head
pp. 117-117(1)
Author: Gross M.

Digital epiluminescence videomicroscopy: a method for improving the diagnosis of pigmented skin lesions
pp. 117-118(2)
Authors: Seidenari S.; Dell'Eva G.; Belletti B.; Pepe P.; Giannetti A.; Burroni M.

The training effect on stratum corneum recompensation mechanisms during irritation by repetitive washings
pp. 118-118(1)
Authors: Grunewald A.M.; Bettinger J.; Gloor M.

The effect of Imedeen(R) in photoaged skin
pp. 118-118(1)
Authors: Kieffer M.E.; Mortensen L.; Efsen J.

Computer aided diagnosis of skin pigmented lesions
pp. 118-118(1)
Authors: Burroni M.; Dell'Eva G.; Santini S.; Alparone L.

Normalization of Langerhans cells (CD1a+) levels in the chronically photoexposed epidermis of aged subjects treated with glycolic acid
pp. 118-119(2)
Authors: Ghersetich I.; Lotti T.

Image analysis of pigmented lesions
pp. 119-119(1)
Authors: Perotti R.; Biagioli M.; Andreassi L.; Burroni M.; Santini S.; Dell'Eva G.

Ultrasonographic and C.T.-scan aspects (skin and viscera) in tuberous sclerosis
pp. 119-119(1)
Authors: Nedelcu I.; Trifu V.; Meclea G.; Ciprut D.

Elastolitic proteases and photoaging
pp. 119-119(1)
Authors: Fimiani M.; Lungarella G.; Cavarra E.; Mazzatenta C.

Effect of a ceramide/cholesterol/FFA--containing body lotion on the barrier function of aged skin
pp. 119-120(2)
Authors: De Paepe K.; Vandenbussche K.; Derde M.P.; Roseeuw D.; Rogiers V.

Somatostatin analogue scintigraphy: a new staging tool in primary cutaneous lymphomas
pp. 120-120(1)
Authors: Heule F.; van den Anker-Lugtenburg P.J.; van Joost T.; Vanhagen P.M.; Lowenberg B.; Lamberts S.W.J.; Reubi J.C.; Oei H.Y.; Krenning E.P.

Malignant blue nevus with distant subcutaneous metastasis
pp. 120-120(1)
Authors: Boni R.; Panizzon R.; Dummer R.

Skin lesions in B-cell chronic lymphocytic leukemia
pp. 120-120(1)
Authors: Bottoni U.; Innocenzi D.; Silipo V.; Calvieri S.; Mauro F.R.; Potente G.

Facial haemangioma, coarctation of the aorta and congenital hypothyroidism
pp. 120-121(2)
Authors: Valari M.D.; Murthy S.; Harper J.I.

Primary neuroendocrine carcinoma of the skin and pheochromocytona express tyrosinase-mRNA. Detection by a specific nested PCR-technique
pp. 121-121(1)
Authors: Alegre M.; Puig L.; Perez M.; de Moragas J.M.; Carreno R.; Baiget H.; del Rio E.; Fernandez-Figueras M.T.

Juvenie cutaneous sclerohyaline fibromatosis with giant subcutaneous fibrohyaline tumour
pp. 121-121(1)
Authors: Nedelcu I.; Trifu V.; Blezu A.

Systematic methorexate in the treatment for keratoacanthoma
pp. 121-121(1)
Authors: Szepietowski J.; Wasik F.

Effect of Russian cytostatic drug prospidin on the different cell types within poikilodermic cutaneous lymphoma
pp. 121-121(1)
Authors: Aravijskaya E.R.; Raznatovskij I.M.; Rybakova M.G.

Indications for radiotherapie in dermatologic oncology
pp. 122-122(1)
Authors: Mulkens P.J.M.; Kreysel H.W.

The role of vertebro-basilar circulation state in the pathogenesis of sensorineural hearing loss for patients with syphilis
pp. 123-123(1)
Authors: Yuldashev A.; Tukhvatullina Z.G.

Trial of single-dose spectinomycin in treatment of uncomplicated gonorrhea in estonia
pp. 123-123(1)
Authors: Uuskula A.; Kivi H.; Poder A.; Vaher R.; Silm H.

A new vulval condition?
pp. 123-123(1)
Authors: Stewart E.; Wojnarowska F.

Treatment of nongonococcal urethritis in men caused by mixed infection with chlamydia trachomatis and ureaplasma urealyticum
pp. 123-123(1)
Authors: Vesic S.; Krunic A.; Martinovic N.; Nedeljkovic M.; Konstantinovic S.

Colposcopical, cytological and histological findings in female patients with STD
pp. 123-124(2)
Authors: Kuzeva V.; Kostova P.; Kamarashev J.; Vlaeva T.; Paskova K.

Cases of atypical syphilis
pp. 124-124(1)
Author: Gailis A.

Dramatic increase in syphilis cases in latvia in 1994
pp. 124-124(1)
Authors: Rubins A.; Hartmane I.; Gutmane R.; Kisis J.

New data in family chlamydiosis
pp. 124-124(1)
Authors: Delektorsky V.V.; Gashkowao G.N.; Shvelidze M.

Intravaginal desensitization in a 29-year-old woman with seminal fluid allergy
pp. 124-124(1)
Authors: De Cuyper C.; Bogaerts Y.; Vandekerckhove F.

Systemic interferon alpha-2A in the treatment of condyloma acuminatum; a preliminary study
pp. 124-124(1)
Authors: Dogan B.; Harmanyeri Y.

Cutaneous hypersensitivity reactions to human seminal fluid
pp. 124-125(2)
Authors: Kalogeromitros D.; Katsarou A.; Kapellou O.; Polizou E.; Zervaki E.; Stratigos I.

Historical aspects of sexually transmitted diseases prevention
pp. 125-125(1)
Authors: Jografakis J.; Ntanaka G.; Mandrakis D.

Reiteroid pattern in aids-associated psoriasiform dermatitis
pp. 125-125(1)
Authors: Romani J.; Puig L.; Baselga E.; Perez M.; de Moragas J.M.

Presence of CMV in skin vesicles or ulcers in AIDS patients
pp. 125-125(1)
Authors: Buezo G.F.; Penas P.F.; Dauden E.; Garcia-Diez A.; Nieto S.

Leishmaniasis presenting as a dermatomyositis-like eruption in AIDS
pp. 125-126(2)
Authors: Dauden E.; Penas P.F.; Rios L.; Fernandez-Herrera J.; Fraga J.; Alvar J.

CMV and HSV ulcers of the HIV(+) patients' genital and perianal region
pp. 126-126(1)
Authors: Stavrianeas N.; Polydorou D.; Botsis C.; Paparizos V.; Zagoreos J.; Vareltzidis A.; Stratigos J.

Multiple dermatofibromas in an HIV-positive patient treated with PUVA
pp. 126-126(1)
Authors: Fuente M.J.; Paradelo C.; Ribera M.; Bielsa I.; Ferrandiz C.; Fernandez M.T.

HIV-associated eosinophilic folliculitis
pp. 126-126(1)
Authors: Gaddoni G.; Baldassari L.; Marinucci I.; Menni B.; Aldi M.

Primary cutaneous cryptococcosis in a HIV infected patient: case report
pp. 126-126(1)
Authors: Tessari G.; Barba A.; Lanzafame M.; Bonora S.

Management of herpesvirus infections in HIV disease
pp. 126-127(2)
Author: Conant M.

TNF-alpha and IL-1 beta in drug addicts during the first years of HIV infection
pp. 127-127(1)
Authors: Chodynicka B.; Sokolowska M.; Andrzejewicz A.; Zbroch T.; Szadkowska B.

Endemic (African) Kaposi sarcoma
pp. 127-127(1)
Authors: Papadavid E.; Yu R.C.; Chu A.C.

Familial Kaposi's sarcoma: four new cases and a review of the literature
pp. 127-127(1)
Authors: Cottoni F.; Masala M.V.; Masia I.M.; Mulargia M.; Contu L.

Peri-lesional therapy with rhGM-CSF for Kaposi's sarcoma
pp. 127-128(2)
Authors: Friedman-Birnbaum R.; Ramon M.; Weltfriend S.; Bergman R.

Efficiency of bleomycine in Kaposi's sarcoma in heart transplant recipient
pp. 128-128(1)
Authors: Modiano P.; Mattei M.F.; Reichert S.; Barbaud A.; Weber M.; Schmutz J.L.

Multiple basocellular carcinomas (BCCs) following Rx-therapy for lumbosacral arthrosis
pp. 128-128(1)
Authors: Baldari U.; Zanelli R.; Monti A.; Righini M.G.

Melanocytic naevi in renal transplant children versus healthy children
pp. 128-128(1)
Authors: Abdel-Hamid I.A.; Sobh M.; Wafa E.; Ghoniem M.

Is there any relationship between melanoma incidence and global sunlight or thickness of the stratospheric ozone layer?
pp. 128-128(1)
Author: Ettler K.

Diffuse cutaneous mastocytosis with reactive monoclonal hypergammaglobulinemia
pp. 128-128(1)
Authors: Cesgarea R.; Pep D.

Fibroepithelioma. Report of 15 cases
pp. 128-129(2)
Authors: Valcayo A.; Vives R.; Santamaria M.; Lozano J.A.; Larrinaga B.

Detection of tyrosinase-mRNA by nested PCR in peripheral blood of patients with malignant melanoma
pp. 129-129(1)
Authors: Alegre M.; Puig L.; Perez M.; de Moragas J.M.; Baiget M.; del Rio E.

Photodynamic therapy of skin tumors using topical 5-aminolevulinic acid
pp. 129-129(1)
Authors: Stefanidou M.; Nikiforos A.; Georgiou S.; Datseris G.; Katsantonis J.; Tosca A.

Keratoacanthoma centrifugum marginatum treated and healed by etretinate
pp. 129-129(1)
Authors: Lo Schiavo A.; Pinto F.; Vozza A.; Ruocco V.

Eccrine squamous syringometaplasia in intertriginous areas. A case report
pp. 129-130(2)
Authors: Valks R.; Buezo G.F.; Dauden E.; Garcia-Diez A.; Fraga J.

High frequency ultrasound in the pre-operative management of melanocytic skin tumours
pp. 130-130(1)
Authors: Ulrich J.; Merk G.; Franke I.; Urbanke D.; Kuhne K.-H.; Gollnick H.

Response to etretinate of a case of squamous cell carcinoma of the skin
pp. 130-130(1)
Authors: del Castillo L.F.; Diez-Caballero N.; Almagro D.G.

Cancer en cuirasse
pp. 130-130(1)
Authors: Sotiriadis D.; Papagarifallou I.; Lazaridou E.; Minas A.

Etretinate (Tigason) and Interferon alpha (Roferon) for treatment of advanced squamous cell carcinoma of the mouth and skin
pp. 130-130(1)
Author: Troyanova P.P.

Basal cell carcinoma a comedo appearing
pp. 130-131(2)
Authors: Castineiras M.T.; Doval I.G.; Garcia M.S.; Toribio J.

A familial variant of multiple dermatofibromas
pp. 131-131(1)
Authors: Yucelten D.; Ergun T.; Kocaayan N.; Gurbuz O.

Congenital smooth muscle hamartoma
pp. 131-131(1)
Authors: Khalilazar R.; Gurbuz O.; Ergun T.; Kocaayan N.

Comparison of the effects of intralesional interferon alpha 2A, 2B and combination of the 2A and the 2B in the treatment of basal cell carcinoma
pp. 131-131(1)
Authors: Alpsoy E.; Yilmaz E.; Basaran E.; Yazar S.

Treatment of aggressive basal cell and squamous cell carcinomas with intralesional interferon alpha-2b
pp. 131-131(1)
Authors: Lopez-Estebaranz J.L.; Ortiz P.; Castano E.; Iglesias L.

Iontophoresis for anesthesia during pulsed dye treatment of port wine stains
pp. 131-131(1)
Authors: Nunez M.; Boixeda P.; Miralles E.S.; De Las Heras M.E.; Perez B.; Ledo A.; Ramon y Cajal H.

Angiocentric T cell lymphoma
pp. 132-132(1)
Authors: Sevila A.; Silvestre J.F.; Morell A.; Roman P.; Banuls J.; Botella R.; Massuti B.; Jimenez M.J.

Cutaneous leukemia. Study of 14 cases
pp. 132-132(1)
Authors: Porras-Luque J.I.; Valks R.; Rios-Buceta L.; Dauden E.; Garcia-Diez A.; Fraga J.

Clinical features of lympoma of the skin in Uzbekistan
pp. 132-132(1)
Authors: Tukhvatullina Z.; Yuldashev A.

Giant congenital nevus degenerating towards disseminated malignant melanoma after a follow-up period of ten years
pp. 132-132(1)
Authors: Vozmediano J.; Romero M.A.; Manrique A.; Nieto I.; Riande P.; Gonzalez A.; Hens A.

Proliferating-cell nuclear antigen (PCNA) and p53 oncoprotein expression in malignant melanoma
pp. 132-133(2)
Authors: Seckin D.; Turanli A.Y.; Ozdamar S.; Ozyilkan O.; Ozyilkan E.; Kandemir B.

Melanoma of unknown primary origin with appearance of cutaneous metastases: a case study
pp. 133-133(1)
Authors: Cagnoni M.L.; Pichi-Graziani M.; Ghersetich I.; Freschi G.; Lotti T.

Cutaneous microcirculation: a comparism between non-insulin dependent diabetics with and without cutaneous manifestations and healthy control subjects
pp. 133-133(1)
Authors: Boateng B.; Hiller D.; Hornstein O.P.

Lesional skin corneometry values correlate with the psoriasis disease severity, with the serum E-Selectin levels and recover after an effective therapy
pp. 133-133(1)
Authors: Ameglio F.; Carducci M.; Mussi A.; Bonifati C.; Fazio M.

Improved method to study skin lipid samples from cyanoacrylate tape strips by high performance thin layer chromatography
pp. 134-134(1)
Authors: Ropke E.M.; Cobau M.; Gollnick H.

In vivo laser doppler evaluation of specific histamine-agonist effects in the skin
pp. 134-134(1)
Authors: Leroy T.; Jadoul A.; Thysman S.; Preat V.; Van Neste D.

Computerized diagnosis of cutaneous pigmented lesions: reality and fantasy this years of research
pp. 134-134(1)
Authors: Bauer P.; Cristofolini P.; Boi S.; Dell'Eva G.; Burroni M.; Cristofolini M.

A method measuring the occlusive ability of a nail lacquer preparation
pp. 134-135(2)
Author: Hatzis J.

Minitel as an informative tool for adverse drug reaction
pp. 135-135(1)
Authors: Bonnetblanc J.M.; Wallach D.; Bouchoux P.; Arrighi C.

Effects of ammonium lactate on cutaneous glycosaminoglycan synthesis by fibroblasts and keratinocytes
pp. 135-135(1)
Authors: Pauwels C.; Boisnic S.; Branchet M.C.; Peyrot J.

Effect of topical glucocorticoids with different anti-inflammatory potencies on type I and III procollagen propeptides in suction blister fluid
pp. 135-135(1)
Authors: Haapasaari K.M.; Oikarinen A.

Plasma concentration of IL-2 and soluble IL-2 receptor in patients in the chosen dermatoses
pp. 135-135(1)
Authors: Lecewicz-Torun B.; Krasowska D.; Chodorowska G.

Bel-2 and P53 immunoreactivity in conjunctival intra-epithelial neoplasia and apocrine carcinoma of the eyelid
pp. 136-136(1)
Authors: Calzolari A.; Faraldi F.; Mincione F.; Cagnoni M.L.; Pignone A.; Lombardi A.; Scaletti C.; Carossino A.; Matucci-Cerinic M.; Lotti T.

Immunohistochemical analysis of p53 and bel-2 in lesional skin of patients afected by systemic sclerosis
pp. 136-136(1)
Authors: Pignone A.; Calzolari A.; Cagnoni M.L.; Carossino A.; Lombardi A.; Scaletti C.; Matucci-Cerinic M.; Lotti T.

Recognition of oncoprotein P-190 by polymerase chain reaction (PCR) in basal cell carcinoma
pp. 136-136(1)
Authors: Teofoli P.; Cagnoni M.L.; Galimberti S.; Ronca P.; Lotti T.

Histamine release in skin prick test reaction monitored by the microdialysis technique
pp. 136-136(1)
Authors: Horsmanheimo L.; Harvima I.; Harvima R.; Horsmanheimo M.

Mast cells inhibit keratinocyte growth
pp. 136-137(2)
Authors: Huttunen M.; Horsmanheimo M.; Harvima I.T.; Nilsson G.

Mast cells in cutaneous herpes zoster
pp. 137-137(1)
Authors: Kaminska R.; Harvima I.T.; Horsmanheimo M.; Naukkarinen A.

Dipeptidyl aminopeptidase IV activity in healing wound and in psoriatic skin
pp. 137-137(1)
Authors: Partanen T.A.; Harvima I.T.; Horsmanheimo M.; Naukkarinen A.

Electrophoteic fractions of urinary porphyrins in porphyria cutanea tarda induced by hexachlorbenzene in rat
pp. 137-137(1)
Authors: Tataru A.; Puia L.; Madar I.; Sildan N.

Measurement of collagen mRNA levels in skin biopsies by quantitative PCR
pp. 137-138(2)
Authors: Tasanen K.; Hamalainen E.R.; Oikarinen A.

Effects of urocanic acid isomers on the secretion of cytokines by keratinocytes
pp. 138-138(1)
Authors: Redondo P.; Espana A.; Quintanilla E.; Cuevillas F.; Garcia-Foncillas J.

CD69, CD31 and factor XIIIa expression in granulomatous reactions
pp. 138-138(1)
Authors: Nikkels A.F.; Nikkels-Tassoudji N.; Pierard G.E.

Histopathologic findings in melanocytic lesions
pp. 138-138(1)
Authors: Pizinger K.; Cetkovska P.

Quantitative characterization of sclerotic skin in localized and systemic scleroderma: image analysis on 20 MHz B-scan recordings
pp. 138-139(2)
Authors: Syad T.A.; Ahmad S.A.; Ahmad S.H.; Sheema K.M.

Collagen is an important modificator of the photodynamic phenomenon in primary keratinocyte cultures
pp. 139-139(1)
Authors: Georgiou S.; Katsantonis J.; Providaki M.; Stefanidou M.; Zoras U.; Tosca A.

Expert system in dermatopathology
pp. 139-139(1)
Authors: Rodionov A.N.; Barbinov V.V.; Samtsov A.V.; Akhmedov I.G.

Skin water-holding capacity and transdermal estrogen therapy for menopause
pp. 139-139(1)
Authors: Pierard-Franchimont C.; Letawe C.; Goffin V.; Pierard G.E.

Effects of tretinoin emollient cream on photodamaged skin: relationship between skin irritation and clinical improvement
pp. 139-140(2)
Authors: Lufrano L.; Thorne E.G.; Boateng F.; Sampson A.R.

Lanolin emolliency: fact or fiction?
pp. 140-140(1)
Authors: Orr S.; Steel I.

An in vitro study of the 5-methoxypsoralen bioavailability by microdialysis
pp. 140-140(1)
Authors: Muret P.; Humbert P.; Makki S.; Belon J.P.; Henry J.C.

Toxicokinetics of topically applied calcitriol and calcipotriol
pp. 140-140(1)
Authors: van Harten J.; Lammers R.

Laser Doppler flowmetry comparison of pharmacodynamic effects of cetirizine and loratadine on histamine induced skin response
pp. 140-140(1)
Authors: Farhoudi A.; Pourpak Z.; Yazdani F.; Motamedi F.

Pigmentatio maculosa multiplex: a variant of ashy dermatosis?
pp. 140-141(2)
Authors: Taniguchi S.; Kono T.; Hayashi A.; Hamada T.; Takahashi K.

A case of congenital self-healing reticulohistiocytosis
pp. 141-141(1)
Authors: Kuniyuki S.; Tsubakio Y.

Garment eruptive pustulosis
pp. 141-141(1)
Authors: Salvo S.; Vives R.; Valcayo A.; Mazon A.; Tunon T.; Navarro de Salud S.

Epiluminescence microscopy: our two-year experience
pp. 141-141(1)
Author: Cozzi R.

Cutis marmorata telangiectatica congenita or neonatal lupus?
pp. 141-141(1)
Authors: Carrascosa J.M.; Ribera M.; Bielsa I.; Fuente M.J.; Ferrandiz C.

Upper eyelid dermatitis syndrome related to Helicobacter pylori positive antrungastritis
pp. 141-141(1)
Authors: Cervenkova D.; Lengyelova J.; Kolibasova K.

Sweet's syndrome associated with multiple myeloma
pp. 142-142(1)
Authors: Stefanidou M.; Karayani M.; Papadakis G.; Katsantonis J.; Tosca A.

Huriez syndrome. A case report
pp. 142-142(1)
Authors: Piacentino M.T.; Didona B.; Sonego G.; Ricci C.; Laurenza M.; Macchini V.; Concolino F.; Atzori F.

Keratitis, ichthyosis, and deafness (KID) syndrome: a case report
pp. 142-142(1)
Authors: Holobrada M.; Ondzikova V.; Danilla T.

Madelung's disease affecting the tongue
pp. 142-142(1)
Authors: Vargas-Diez E.; Jones-Caballero M.; Dauden E.; Sanchez-Perez J.; Gil-Diez J.L.

Pyoderma gangrenosum appeared after cutaneous surgery in a chronic HCV hepatitis's patient
pp. 142-142(1)
Authors: Rizzi G.M.; Mattighello P.; Coletti C.; Trevisan G.

Erythema gyratum repens. A case report
pp. 143-143(1)
Authors: Vidimari P.; Sclaunich S.; Rizzi G.M.; Trevisan G.; Sandri P.

Palmoplantar keratoderma, woolly-hair with pili torti, lingua plicata and polycystic ovaries
pp. 143-143(1)
Authors: Danopoulou I.; Zahari A.; Gourgiotou K.; Michelakis M.; Hatziolou E.; Zografakis J.

Erythema gyratum repens: a clinical and immunohistochemical study
pp. 143-143(1)
Authors: Gravante M.; Masci S.; Andreassi M.; Rotoli V.; Amerio P.; Angelucci D.

Generalised keratosis suprafollicularis with ulerythema ophryogenes associated with Ullrich-Turner syndrome
pp. 143-143(1)
Authors: Rosin C.; Monike K.; Krebs P.; Franke I.; Koditz H.; Wieacker P.F.; Gollnick H.P.M.

Reticular pigmented cutaneous mucinosis: a new distinct entity
pp. 143-144(2)
Authors: Noto G.; Pravata G.; Arico M.

Childhood pemphigus: report of two gases with HLA-study
pp. 144-144(1)
Authors: Vassileva S.; Mateev G.; Martinova D.; Stoimenov A.

Congenital ichthyosiform erythroderma (CIE) -- ultrastructural evidences of abnormal stratum corneum retention
pp. 144-144(1)
Authors: Nicolae M.; Toma C.

Coexistence of xanthoma and amyloidosis in cutaneous lesions of a patient with a monoclonal gammapathy
pp. 144-144(1)
Authors: Buezo G.F.; del Rio M.R.; Aragues M.; Dauden E.; Fraga J.

Idiopathic palmar hidradenitis
pp. 144-144(1)
Authors: Pereda J.; Abbad E.; Ruffin J.; Ortiz S.; Gonzalez J.; Requena L.

Macular amyloidosis (report of 7 cases)
pp. 144-145(2)
Authors: Tufan H.; Ergenekon G.; Basak T.; Tirpanci A.; Aybey B.; Yildiz H.

Disseminated granuloma annulare in a patient with transitory hyperthyroidism
pp. 145-145(1)
Authors: Rizzi G.M.; Mattighello P.; Coletti C.; Trevisan G.

Cutaneous sarcoidosis and foreign body reaction
pp. 145-145(1)
Authors: Lefaki I.; Mourellou O.; Karakatsanis G.; Kapetis E.

Elastosis perforans serpiginosa (EPS) associated with focal dermal hypoplasia (FDH)
pp. 145-145(1)
Authors: Nikolic M.M.; Lalevic-Vasic B.; Karadaglic D.; Goldner B.; Milinkovic M.

Sweet's syndrome in a therapeutic agranulocytosis stage
pp. 145-145(1)
Authors: Iniesta J.F.; Sanchez-pedreno P.; Lazaro A.M.; Perez J.S.

Treatment of psoriasis: mathematical model of membrane ionic transport
pp. 145-146(2)
Authors: Stuly O.N.; Mavrov I.I.; Tugaev A.S.

Aloe vera extract in a hydrophilic cream for the management of psoriasis. A placebo-controlled, double-blind study
pp. 146-146(1)
Authors: Ahmad S.A.; Ahmad S.H.; Cheema K.M.; Syed T.A.

A double blind clinical trial of FK-506 (tacrolimus) in 16 patients with psoriasis
pp. 146-146(1)
Authors: Rubins A.; Hartmane I.

Genetic polymorphisms of the S gene in the HLA class I region and psoriasis vulgaris
pp. 146-146(1)
Authors: Ozawa A.; Sugai J.; Kawakubo Y.; Miyahara M.; Iizuka M.; Ohkido M.; Ishihara A.; Yamagata N.; Ohno S.; Inoko H.

The method of evaluation for prognosis with the averaged psoriasis area and severity index
pp. 146-146(1)
Authors: Sugai J.; Ozawa A.; Kawakubo Y.; Miyahara M.; Iizuka M.; Ohkido M.

Treatment of psoriasis with plapheron
pp. 146-147(2)
Authors: Leonidze T.; Tevsadze M.

Comparison of proliferative activity in psoriasis and squamous cell carcinoma assessed by proliferating-cell nuclear antigen expression and argyrophilic nucleolar organizer region staining
pp. 147-147(1)
Authors: Seckin D.; Turanli A.Y.; Ozdamar S.; Yildiz L.; Yavuz I.; Kandemir B.

Validation studies of the self-administered psoriasis area severity index (SAPASI)
pp. 147-147(1)
Authors: Fleischer A.B.; Feldman S.R.; Reboussin D.M.; Exum M.L.; Clark A.R.; Rapp S.R.

Clinical and biological effects of a selenium-rich thermal water on psoriasis vulgaris
pp. 147-147(1)
Authors: Pinton J.; Friden H.; Kettaneh-Wold N.; Wold S.; Dreno B.; Richard A.; Rougier A.; Bieber T.

Plasma concentrations of calcitriol in psoriasis patients treated with calcitriol ointment
pp. 147-148(2)
Authors: van Harten J.; Boon C.

Clinical study of ciclosporin therapy on psoriasis: comparative study between long-term monotherapy and long-term intermittent administration
pp. 148-148(1)
Authors: Nakayama J.; Hori Y.; Kitahara H.; Nakagawa H.; Ohtsuki M.; Horikoshi T.; Hanada J.; Ozawa A.; Sugai J.; Okido M.

5 and 10 days occlusive treatment with calcipotriol ointment in scalp psoriasis
pp. 148-148(1)
Author: Kose O.

Calcitriol ointment for the treatment of facial, hairline and retroauricular psoriasis
pp. 148-148(1)
Authors: Langner A.; Stapor W.

Topical vitamin D derivate in treatment of psoriasis vulgaris
pp. 148-148(1)
Authors: Uuskula A.; Kangur A.; Silm H.; Majass M.; Elberg E.; Kaur S.; Rajahgu H.

High-dose ranitidine in the treatment of psoriasis, I. clinical results
pp. 148-149(2)
Authors: The Copenhagen Ranitidine Psoriasis Study Group; Kristensen J.K.; Petersen L.J.; Hansen U.; Nielsen H.; Skov P.S.; Nielsen H.J.

Use of systemic treatment in psoriasis -- a comparative study
pp. 149-149(1)
Authors: Gatt P.; Boffa M.; Scerri D.; Pace J.L.

High-dose ranitidine in the treatment of psoriasis, II. Local immunology
pp. 149-149(1)
Authors: The Copenhagen Ranitidine Psoriasis Study Group; Petersen L.J.; Hansen U.; Nielsen H.J.; Kristensen J.K.; Nielsen H.; Skov P.S.

High-dose ranitidine in the treatment of psoriasis, III. Systemic immunology
pp. 149-149(1)
Authors: The Copenhagen Ranitidine Psoriasis Study Group; Nielsen H.J.; Nielsen H.; Petersen L.J.; Hansen U.; Kristensen J.K.; Skov P.S.

Lichen sclerosus et atrophicus versus morphea
pp. 149-149(1)
Authors: Sanchez-Pedreno P.; Iniesta J.F.; Perez J.S.; Caballero L.R.

Lichen striatus
pp. 149-150(2)
Authors: Pinna A.L.; Aste N.; Biggio P.

On the subject of lichen planus of palms and soles
pp. 150-150(1)
Author: Houset J.

Tufted hair folliculitis: report of 3 cases
pp. 150-150(1)
Authors: Aybey B.; Ergenekon G.; Evren I.; Tirpanci A.; Koyuncu M.; Tufan H.; Aksoy M.

The treatment of alopecia areata with topical minoxidil and anthralin
pp. 150-150(1)
Authors: Broniarczyk-Dyla G.; zak-Prelich M.

Heterocromic hair in the scalp
pp. 150-150(1)
Authors: Wilhelmi M.L.; Wilhelmi J.O.; Sierra J.O.; Campos A.; Crespo V.

The mechanism of inheritance of androgenetic alopecias in women
pp. 150-150(1)
Authors: Martinovic N.; Krunic A.; Vesic S.; Diklic V.; Konstantinovic S.

Treatment of alopecia areata with sensitizing agents: a review of 140 cases
pp. 150-150(1)
Authors: Delfino M.; Procaccini E.M.; Sammarco E.; Scalvenzi M.

Topical photochemotherapy of alopecia areata: two years experience
pp. 151-151(1)
Authors: Delfino M.; Procaccini E.M.; Sammarco E.; Scalvenzi M.

Seasonal variations in polymorphic nail surface changes associated with diabetes mellitus
pp. 151-151(1)
Authors: Nikkels-Tassoudji N.; Letawe C.; Pierard-Franchimont C.; Pierard G.E.

Characterization and distribution of Langerhans' cells within the nail matrix
pp. 151-151(1)
Authors: Cameli N.; Tosti A.; Picardo M.; Betts C.M.; Ortonne J.P.

Helicobacter pylori seroprevalence in patients with acne rosacea
pp. 151-151(1)
Authors: Erel A.; Oztas M.; Ilter N.; Senol E.; Sultan N.; Gurer M.A.

Clinical implications of mild cleansing products for individuals undergoing acne therapy with tretinoin
pp. 151-151(1)
Authors: Nicoll G.; Barrows J.; Murahata R.; Greene A.; Leyden J.; Grove G.

A controlled, randomized study comparing the efficacy of a 3% erythromycin and 5% benzoyl peroxide combination gel with clindamycin phosphate lotion for the treatment of acne vulgaris
pp. 152-152(1)
Authors: Packman A.M.; Brown R.; Webster G.F.

Comparison of clinical safety and efficacy of adapalene gel and tretinoin gel in the treatment of acne vulgaris
pp. 152-152(1)
Authors: Cunliffe W.J.; Orfanos C.; Caputo R.; Forstrom L.; Hennen M.; Privat Y.; Dreno B.; Aguilar A.R.; Czernielewski J.; Poncet M.; Verschoore M.

Clinical safety and efficacy comparison of adapalene solution and Retin-A gel in the treatment of acne vulgaris
pp. 152-153(2)
Authors: Ellis C.N.; Chalker D.K.; Millikan L.E.; Smith E.B.; Swinyer L.J.; Katz I.H.; Berger R.S.; Mills O.H.; Lederman J.S.; Czernielewski J.; Baker M.D.

Clinical safety and efficacy comparison of adapalene gel and Retin-A gel in the treatment of acne vulgaris
pp. 153-153(1)
Authors: Shalita A.; Weiss J.S.; Chalker D.K.; Ellis C.N.; Greenspan A.; Katz H.I.; Kantor I.; Millikan L.E.; Swinehart J.; Swinyer L.J.; Whitmore C.; Czernielewski J.; Baker M.D.

Subjects using anti-dandruff shampoos
pp. 153-153(1)
Authors: Pierard-Franchimont C.; Pierard G.E.

In-vitro study of cleanser induced structural changes in skin
pp. 153-154(2)
Authors: Mukherjee S.; Prowell S.; Davies M.; Meyers L.; Hoyberg K.; Gursky R.; Aronson M.P.

Influence of intensive cleansing on sebum production
pp. 154-154(1)
Authors: Sharko P.T.; Kligman A.M.

Contact hypersensitivity to topical corticosteroids
pp. 154-154(1)
Authors: Tunali S.; Saricaoglu H.; Alpakut S.

Transparent hydrocolloid dressing as a support for the patch test
pp. 154-154(1)
Authors: Vidal-Asensi S.; Luelmo-Granados L.

Lanolin allergy: hype or hypersensitivity?
pp. 154-154(1)
Authors: Steel I.; Orr S.

Red Sea coral contact dermatitis
pp. 154-154(1)
Authors: Albanese G.; Di Cintio R.; Galbiati G.

Sea bather's eruption
pp. 155-155(1)
Authors: Albanese G.; Di Cintio R.; Galbiati G.

A series of cases from a tropical dermatology clinic in Italy
pp. 155-155(1)
Authors: Albanese G.; Di Cintio R.; Galbiati G.

Expression of thrombospondin-1 (TSP) in healthy and diseased skin
pp. 155-155(1)
Authors: Begany A.; Simon M.; Hunyadi J.; Dehmel N.

Livedo with nodules: cutaneous polyarteritis nodosa in a renal transplant patient
pp. 155-155(1)
Authors: De Cuyper C.; Hinderyckx P.; Goeteyn M.

Immunologic studies on lymphomatoid papulosis (LyP)
pp. 155-155(1)
Authors: Ortiz-Romero P.L.; Corell-Almuzara A.; Lopez-Estebaranz J.L.; Diez L.I.

Immediate allergic reaction to recombinant human insulin successfully treated by local injectable corticotherapy
pp. 156-156(1)
Authors: Barbaud A.; Modiano P.; Reichert S.; Weber M.; Schmutz J.L.

Immunogenic activity of ingested nickel in women with nickel allergic dermatitis
pp. 156-156(1)
Authors: Andreassi M.; Masci S.; Gravante M.; Amerio P.; Di Gioacchino M.; Iasonna G.; Cervone M.; Cavallucci E.; Pavone G.; Boscolo P.

HLA DR, DQA1, DQB1 and DP antigens in patients allergic to nickel
pp. 156-156(1)
Authors: Onder M.; Aksakal B.; Gulekon A.; Maki S.; Oztas M.; Barut A.

Urticaria due to dyes of textile fibers
pp. 156-156(1)
Authors: Pauluzzi P.; Antonini E.; Rizzi G.M.

Serum lipoprotein (a) levels in patients with Behcet's disease
pp. 156-157(2)
Authors: Seckin D.; Oltulu Y.; Canturk T.; Turanli A.Y.; Akpolat T.; Erkan D.; Adam B.

Progressive systemic scleroderma/systemic lupus erythematosus overlap syndrome rapidly progressive with spontaneous regression of a facial angioma
pp. 157-157(1)
Authors: Zografakis G.; Ntanakia G.; Mandrakis D.

Scleredema associated to diabetes mellitus. Study of two cases
pp. 157-157(1)
Authors: Jones-Caballero M.; Dauden E.; Penas P.F.; Fraga J.; Garcia-Diez A.

Lupus erythematosus (LE)/lichen ruber planus (LP)-overlap-syndrome: 4 new cases in the review of last decade's inhouse-patients
pp. 157-157(1)
Authors: Mahler V.; Albrecht H.P.; Kiesewetter F.

Systemic scleroderma treatment with D-penicillamine
pp. 157-158(2)
Authors: Semradova V.; Navratilova Z.

Dermatomyositis: a retrospective study of 34 inpatients
pp. 158-158(1)
Author: Dourmishev L.A.

Coexistence of generalized morphea and lichen sclerosus et atrophicus
pp. 158-158(1)
Authors: Alper S.; Ozdemir F.; Unal I.; Ozturk G.; Kandiloglu G.; Kazandi A.C.; Ozkara G.; Erboz S.

A case of lupus panniculitis responding to non-steroid anti-inflammatory drug
pp. 158-158(1)
Authors: Ilter N.; Gurer M.A.; Maki S.; Gencalioglu Y.; Ataoglu O.

Ozonetherapy in localized scleroderma
pp. 158-158(1)
Authors: Smirnov A.V.; Pestova M.Y.; Krivatkin S.L.; Krivatkina E.V.; Ivanova O.A.

Cutaneous manifestations in 15 patients with primary biliary cirrhosis
pp. 158-159(2)
Authors: Sols M.; Valks R.; Moreno R.; Aragues M.; Herrera J.F.

Pemphigus herpetiformis in a lung cancer patient
pp. 159-159(1)
Authors: De Cuyper C.; Hinderyckx P.; Goeteyn M.; van Renterghem D.

Genetic predisposition to pemphigus vulgaris in Sardinian and Central Italian populations: a DNA study
pp. 159-159(1)
Authors: Cottoni F.; Carcassi C.; Floris L.; Baldini G.; Mulargia M.; Vacca A.; Masala M.V.; Cerimele D.; Contu L.

Epidermolysis bullosas with eosinophils
pp. 159-159(1)
Authors: Saenz-Santamaria M.C.; Garcia-Latasa F.J.; Gilaberte Y.; McNutt N.S.

Subcorneal pustular dermatosis diagnostic challenge and therapeutic implications
pp. 159-160(2)
Authors: Mourellou O.; Chaidemenos G.C.; Lefaki I.; Kapetis E.

Pemphigus triggered by topical sensitizer and sunlight
pp. 160-160(1)
Authors: Milinkovic M.; Nikolic M.; Lalevic-Vasic B.

A clinical case of pseudo-porphyria cutanea tarda by hemodialysis
pp. 160-160(1)
Authors: Tataru A.; Vladutiu D.; Puia L.; Gavan N.

A new preparation of khellin in the topical treatment of vitiligo
pp. 160-160(1)
Authors: Orecchia G.; Malagoli P.G.

The use of new agent with immunomodulatory and antiinflammatory activity in the dermatology
pp. 160-160(1)
Authors: Ismailova G.A.; Tukhvatullina Z.G.; Yuldashev K.A.

Antiinflammatory effect of chloroquine in lipodermatosclerosis
pp. 160-160(1)
Authors: Cosgarea R.; Pop D.

Thalidomide in dermatological therapy
pp. 161-161(1)
Authors: Fazic M.; Carducci M.; Fazic R.; Lisi S.; Menaguale G.; Mussi A.; Sacerdoti G.

Effect of oral 9-cis retinoic acid on sebum excretion in human
pp. 161-161(1)
Authors: Hommel L.; Harms M.; Geiger J.-M.; Saurat J.-H.

Etretinate treatment in Gardner's syndrome
pp. 161-161(1)
Authors: Szegedi A.; Ladanyi E.; Hunyadi J.

Cyclosporin in the treatment of generalized granuloma annulare
pp. 161-161(1)
Authors: Chaidemenos G.C.; Mourellou O.; Karakatsanis G.; Koussidou T.

Therapy of livedoid vasculitis
pp. 161-161(1)
Authors: Mourellou O.; Chaidemenos G.C.; Karakatsanis G.; Lefaki I.

Livedo vasculitis-treatment with colchicine
pp. 162-162(1)
Authors: Gantcheva M.; Kiriakova N.; Obreshkova E.; Tsankov N.

Topical methylprednisolone aceponate (Advantan^TM) in the treatment of eczema: results of the Swiss multicentric phase IV-study
pp. 162-162(1)
Author: Elsner P.

Cyclosporine in dermatology -- the UAE experience
pp. 162-162(1)
Author: Shareeah A.M.A.

Treatment of pyoderma gangrenosum with cyclosporine
pp. 162-162(1)
Authors: Gasior-Chrzan B.; Stenvold S.E.; Falk E.S.

Prevention of lesion development in recurrent genital herpes with oral valaciclovir
pp. 162-162(1)
Authors: Valaciclovir HSV Int. Study Group; Kinghorn G.I.; Fiddian A.P.

Can we improve management of perinatal HSV infections?
pp. 162-163(2)
Authors: International Herpes Management Forum IHMF; Kroon S.; Whitley R.J.

Retrograde intravenous pressure infusion technique in the treatment of phlegmon in diabetic patient
pp. 163-163(1)
Authors: Cagnoni M.L.; Vannucchi P.L.; Berti G.; Lotti T.

Melatonin in the treatment of cutaneous sarcoidosis
pp. 163-163(1)
Authors: Cagnoni M.L.; Pignone A.; Lombardi A.; Lotti T.

Retrograde intravenous pressure infusion technique in the treatment of cutaneous necrotizing vasculitis
pp. 163-163(1)
Authors: Vannucchi P.L.; Cagnoni M.L.; Lotti T.

Split skin grafting on severely damaged skin -- a technique using absorbable tissue adhesive
pp. 163-164(2)
Authors: Zaki I.; Millard L.G.

Local skin flaps on the cheek
pp. 164-164(1)
Authors: Vicente J.; Vaz Doval F.J.; Iglesias M.E.; Redondo P.; De Felipe I.; Quintanilla E.

Dermatofibrosarcoma protuberans -- a retrospective study of 17 cases
pp. 164-164(1)
Authors: Sachse M.F.; Amaro J.A.; Pecegueiro M.; Cabecadas J.; Marcos R.; Freitas J.P.; Correia M.

Soluble interleukin-2 receptor in sera from patients with systemic sclerosis
pp. 164-164(1)
Authors: Lis A.; Brzezinska-Wcislo L.; Kulawik I.

The percutaneous absorption of topically applied tretinoin and its effect on endogenous concentration
pp. 164-164(1)
Authors: Latriano L.; Wills R.; Wong F.

Retinoid decreases the apolipoprotein E secretion of monocytes
pp. 165-165(1)
Authors: Remenyik E.; Horkay I.; Paragh G.; Foris O.

Interaction between antimycotics and triazolam
pp. 165-165(1)
Authors: Varhe A.; Olkkola K.T.; Neuvonen P.J.

Photoinduced toxic epidermal necrolysis by clobazam
pp. 165-165(1)
Authors: Vicente J.; Redondo P.; Espana A.; Iglesias M.E.; Quintanilla E.; Subira M.L.

Incidence of systemic reactions to penicillin in patients evaluated for penicillin sensitivity by skin testing and rast
pp. 165-165(1)
Authors: Kalogeromitros D.; Katsarou A.; Kapellou O.; Polizou E.; Zervaki E.; Stratigos I.

A comparison of the systemic effects of fluticasone propionate ointment and betamethasone valerate
pp. 166-166(1)
Authors: Young M.M.R.; Sohail S.; Harding S.M.

Late consequences of thermal injuries
pp. 166-166(1)
Authors: Erdei I.; Tamas A.; Juhasz I.; Hunyadi J.

Assessment of cardiac effects of terfenadine, cetirizine, loratadine and acrivastine
pp. 166-166(1)
Authors: Erel A.; Cengel A.; Oztas M.; Ilter N.; Gurer M.A.

Cutaneous adverse drug reactions in a hospital setting
pp. 166-166(1)
Authors: Rademaker M.; Oakley A.; Duffill M.B.

Cutaneous ulcerations following alpha interferon therapy
pp. 166-166(1)
Authors: Vives R.; Valcayo A.; Perez-Equiza E.; Salvo S.; Martinez-Penuela J.M.; Gastearena J.

Intracellular production of superoxide anion in photodynamic therapy with ala
pp. 166-167(2)
Authors: Gilaberte Y.; Saenz-Santamaria M.C.; Carapeto F.J.; Pereboom D.; Alda J.O.

Programmed coagulation in the treatment of the telangiectases
pp. 167-167(1)
Authors: Comacchi C.; Lotti T.

Intra-individual variation of hidradenitis suppurativa
pp. 167-167(1)
Authors: Jemec G.B.E.; Hultberg B.; Hansen U.

Cutaneous tuberculosis: an unusual case
pp. 167-167(1)
Authors: Bajanca R.; Feio A.B.; Apetato M.; Costa M.M.; Exposto F.; Prieto E.

Serology of lyme borreliosis in some dermatoses (preliminary study)
pp. 167-167(1)
Authors: Acar M.A.; Denli Y.G.; Memisoglu H.R.; Kurt H.; Ozturk C.; Koksal F.

Lupus vulgaris: two atypical cases
pp. 167-167(1)
Authors: Peteiro C.; Doval I.G.; Ferreiro B.R.; Ginarte M.; Rodriguez L.; Aguilar D.S.; Zulaica A.; Toribio J.

Congenital varicella syndrome
pp. 168-168(1)
Authors: De Moor A.; Atherton D.J.

Effectiveness of intralesional azelaic acid in common warts
pp. 168-168(1)
Authors: Onsun N.; Atiganoglu U.; Nisanci P.; Beycan I.; Uras A.R.

Clinical studies and molecular epidemiology of Molluscum contagiosum virus in Spanish isolates
pp. 168-168(1)
Authors: Lopez-Estebaranz J.L.; Funes J.M.; Iglesias L.; Martin-Gallardo A.

The safety of valaciclovir in immuno-competent patients in phase I-III clinical trials
pp. 168-168(1)
Authors: Tilson H.H.; Boone G.; Brown J.; Murray A.B.

Post-herpetic neuralgia (PHN) analysed by intent-to-treat (ITT)
pp. 168-168(1)
Author: Fiddian A.P.

Efficacy of acyclovir in herpes zoster -- a meta-analysis
pp. 169-169(1)
Authors: Wood M.J.; Kay R.

Reducing the burden of zoster-associated pain-update
pp. 169-169(1)
Author: Wood M.J.

Acyclovir suppresses subclinical shedding of HSV-2 in the genital tract
pp. 169-169(1)
Authors: Wald A.; Barnum G.; Selke S.; Davis G.; Zeh J.; Corey L.

Nine year effectiveness of continuous suppressive therapy with acyclovir (ACV) in patients with recurrent genital herpes (RGH)
pp. 169-169(1)
Authors: Acyclovir Study Group; Baker D.A.; Safrin S.; Deeter R.G.; Walker A.; Barton G.

Intravenous immunoglobulin vs acyclovir in treatment of recurrent genital herpes: a clinical and immunological study
pp. 169-170(2)
Authors: Masci S.; Gravante M.; Andreassi M.; Amerio P.; De Simone C.; Ciancarelli M.; Famularo G.

Management of genital herpes in males with human leukocyte interferon- in a hydrophilic cream A placebo-controlled, double-blind study
pp. 170-170(1)
Authors: Ahmad S.A.; Ahmad S.H.; Syed T.A.; Cheema K.M.

A bioadhesive vaginal cream formulation of flutrimazole: tolerance and vaginal retention study in healthy volunteers
pp. 170-170(1)
Authors: Izanierdo I.; Conte L.; Videla S.; Ramis J.; Paredes I.; Forn J.

Clinical and mycological characteristics of tinea favosa
pp. 170-170(1)
Authors: Erdem C.; Kundakci N.; Gurler A.

Itraconazole therapy of doubled fungal infection -- generalized candidosis and dermatophytosis in patients with necrolysis epidermica toxica lyell
pp. 170-170(1)
Authors: Baumgartner J.; Kolibasova K.; Vollekova A.

Oral fluconazole vs. oral fluconazole and topical tioconazole solution treatment in distal onycomycoses
pp. 171-171(1)
Author: Kose O.

An open clinical pilot study of the efficacy and safety of 1% cream of terbinafine in the topical treatment of tinea capitis and tinea cutis glabrae in children
pp. 171-171(1)
Authors: Urbanowski S.; Gwiezdzinski Z.; Nierebinska E.

Long term evaluation of terbinafine (lamisil) 250 mg/day and 500 mg/day in a 16 week oral treatment of toenail onychomycosis
pp. 171-171(1)
Author: De Cuyper C.

Tinea capitis in adults
pp. 171-171(1)
Authors: Feio A.B.; Claro C.; Pinto A.

Efficacy of oral terbinafine treatment in tinea capitis in children caused by mycrosporum canis
pp. 171-172(2)
Authors: Dragos V.; Podrumac B.; Kralj B.; Bartenjev I.

Pilot study of lamisil in the treatment of tinea capitis in microsporum canis infected prepubertal children
pp. 172-172(1)
Authors: Karelson M.; Parna E.; Slim H.; Majass M.; Rajangu H.

Efficacy and tolerability of lamisil (terbinafine) tablets in the treatment of children with tinea capitis
pp. 172-172(1)
Authors: Talarico Fo. S.; Arruda L.H.F.; Cuce L.C.; Foss N.T.; Gontijo B.; Marques S.A.; Santamaria J.R.; Souza E.M.

Efficacy and safety of terbinafine by oral route on treatment of onychomycosis in renal transplant patients
pp. 172-172(1)
Authors: Margarido-Marchese L.; Cuce L.C.; Chocair P.R.; Neto E.D.; Sabagga E.; Salebian A.; D'Alessio M.L.

The comparison of the effects of 1% terbinafin and izoconasole creams in treatment of ptyriasis versicolor
pp. 172-172(1)
Authors: Unlu S.; Ozturkcan S.; Marufihah M.

Candida folliculitis smilar tinea barbae
pp. 172-173(2)
Authors: Kapdagli H.; Ozturk G.; Inci R.; Dereli T.; Hilmioglu S.; Kazandi A.C.; Erboz S.

Efficacy of itraconazole pulse therapy for the treatment of nondermatophyte onychomycosis of the toenail
pp. 173-173(1)
Authors: De Doncker P.; Scher R.; Baran R.; Gupta A.K.; Willemsen R.; Heremans A.; Stoffels P.; Degreef H.; Pierard G.

Itraconalzole vs. griseofulvin in treatment of tinea capitis
pp. 173-173(1)
Author: Al Rubaie S.

Itraconazole in tinea pedis: a dose of 400 mg/day given for 1 week is more effective than 100 or 200 mg/day given for 2-4 weeks
pp. 173-173(1)
Authors: Gupta A.; De Doncker P.; Heremans A.; Stoffels P.; Pierard G.E.; Decroix J.; Heenen M.; Degreef H.

Intermittent pulse therapy with itraconazole in onychomycosis: an update
pp. 173-174(2)
Authors: Andre J.; De Doncker P.; Ginter G.; Stoffels P.; Heremans A.; Roseeuw D.

Cutaneous leishmaniasis in the District of Cagliari
pp. 174-174(1)
Authors: Aste N.; Pau M.; Ferreli C.; Biggio P.

Imported onchocergiasis in Spain
pp. 174-174(1)
Authors: Fonseca E.; del Pozo J.; del Castillo F.; Contreras F.; Cuevas J.

Infantile digital fibromatosis: a case with remarkably evident clinical features
pp. 174-174(1)
Authors: Longo F.; Bohm P.

Diaper dermatitis with papyraceous skin
pp. 174-174(1)
Authors: Patrizi A.; Neri I.; Trevisi P.; Bardazzi F.

Lymphocytes' soluble receptors in atopic dermatits: are they clinically useful?
pp. 174-175(2)
Authors: Paradisi M.; De Pita O.; Ruffelli M.; Frezzolini A.; Cadoni S.; Cianchini G.; Colonna L.; Puddu P.

Immunological classification of atopic dermatitis: a key for immunomodulation therapy
pp. 175-175(1)
Authors: Sergeev Y.V.; Ushakova T.I.; Malyshev V.S.; Sergeev A.Y.

Delayed hypersensitivity to dermatophagoides pteronyssinus in atopic dermatitis
pp. 175-175(1)
Authors: Silny W.; Czarnecka-Operacz M.; Piotrowski M.

Patch tests with mite allergens in patients with atopic dermatitis and healthy volunteers
pp. 175-175(1)
Authors: Manzini B.M.; Schiavi M.E.; Donini M.; Conti A.; Motolese A.; Seidenari S.

Treatment of atopic hand eczema with ranitidine. A double-blind, placebo-controlled trial
pp. 175-175(1)
Authors: Veien N.K.; Larsen P..; Nielsen A.O.; Thestrup-Pedersen K.

Treatment of severe atopic eczema in childhood with cyclosporin
pp. 176-176(1)
Authors: Emerson R.; Zaki I.; Allen B.R.

Sunscreen sensitization: a five year study
pp. 176-176(1)
Authors: Journe F.; Marguery M.C.; Rakotondrazafy J.; El Sayed F.; Bayle-Lebey P.; Bazex J.

Bullous chicken-pox limited to the photoexposed skin: case report
pp. 176-176(1)
Authors: Tessari G.; Schena D.; Chieregato C.; Barba A.

Photo-dermatitis due to Ammi majus
pp. 176-176(1)
Authors: Pauluzzi P.; Giordani M.; Tubaro A.; Kokelj F.

The recovering time of mice Langerhans cell depleted by a single visible light exposure
pp. 176-177(2)
Authors: Procaccini E.M.; Schettino A.; Riccio G.; Calabro G.; Monfrecola G.

Bioengineering methods for assessment of photoaged skin
pp. 177-177(1)
Authors: Efsen J.; Kieffer M.E.

Treatment of hypertensive venous leg ulcers with nifedipine
pp. 177-177(1)
Author: Nikolova K.

Treatment of chronic leg ulcers with fibronectin
pp. 177-177(1)
Authors: Orasan R.; Gavan N.; Has C.

Planimetry of the healing rate of leg ulcers
pp. 177-177(1)
Authors: Pierard G.E.; Pierard-Franchimont C.

Locally used fibrolan solution and ointment in the treatment of ulcers
pp. 177-178(2)
Authors: Silm H.; Kaur S.; Uuskula A.; Vaher R.; Karelson M.; Rajangu H.

Treatment of ulcus cruris with opsite flexigrid dressing
pp. 178-178(1)
Authors: Kolibasova K.; Sevcekova A.; Ondrusova L.

Needle induced purpuric lesions in cutaneous vasculitis
pp. 178-178(1)
Authors: Mat M.C.; Uygun N.; Moghadem M.; Tuzuner N.; Yurdakul S.; Tuzun Y.; Yazici H.

PUVA treatment for alopecia areata
pp. 178-178(1)
Authors: Denli Y.G.; Memisoglu H.R.; Acar M.A.

Is alopecia areata a seasonal disease?
pp. 178-178(1)
Authors: d'Ovidio R.; d'Ovidio F.

Occupational allergy caused by spathe flower (Spathiphyllum wallisii)
pp. 179-179(1)
Authors: Kanerva L.; Makinen-Kiljunen S.; Kiistala R.; Granlund H.

Statistics occupational dermatoses in Finland
pp. 179-179(1)
Authors: Kanerva L.; Jolanki R.; Estlander T.

Statistics on allergic patch test reactions caused by acrylate compounds including data on ethyl methacrylate
pp. 179-179(1)
Authors: Kanerva L.; Estlander T.; Jolanki R.

Occupational allergic contact dermatitis from 2-hydroxyethyl methacrylate and ethylene glycol dimethacrylate in an aerobic acrylic adhesive
pp. 179-179(1)
Authors: Kanerva L.; Jolanki R.; Leino T.; Estlander T.

Immune pharmacology of skin diseases
pp. 181-181(1)
Author: Stingl G.

Individualized short-course cyclosporin therapy in psoriasis
pp. 181-181(1)
Author: Finzi A.F.

The long-term safety and efficacy of cyclosporin A in severe refractory atopic dermatitis: a comparison of two dosage regimens
pp. 181-181(1)
Authors: Zonneveld I.M.; De Rie M.A.; Bos J.D.

Systemic therapy of atopic dermatitis -- experience in children
pp. 181-182(2)
Authors: Zaki I.; Allen B.R.

Less common immune-mediated skin diseases
pp. 182-182(1)
Author: Ruzicka T.

An introduction to Neoral(R) (cyclosporin A)
pp. 182-182(1)
Author: Smith S.G.

Preliminary experience with a novel oral formulation of cyclosporin (Neoral(R))
pp. 182-182(1)
Author: Berth-Jones J.

Markers of the allergic inflammation
pp. 182-182(1)
Author: Venge P.

Epidemiology and prevalence of atopic dermatitis
pp. 182-183(2)
Authors: Abeck D.; Ring J.

A new tool to evaluate atopic dermatitis (SCORAD)
pp. 183-183(1)
Author: Oranje A.P.

Common facts between the urticarial reaction and atopic dermatitis: the role of cetirizine
pp. 183-183(1)
Author: Coulie P.J.

From atopic dermatitis to asthma
pp. 183-183(1)
Author: Warner J.O.

Psoriasis in children -- clinical aspects and therapeutic management indications for topical calcipotriol
pp. 183-184(2)
Author: Beylot C.

Strategies for long term management of psoriasis
pp. 184-184(1)
Author: Ramsay C.A.

Calcipotriol combined with phototherapy (UVB or PUVA) in the treatment of psoriasis
pp. 184-184(1)
Author: Molin L.

Calcipotriol cream and concurrent corticosteroids in psoriasis
pp. 184-184(1)
Author: van de Kerkhof P.C.M.

Vitamin D -- future perspectives
pp. 184-184(1)
Author: Kragballe K.

Incidence and pathophysiology of atopic dermatitis
pp. 184-185(2)
Author: Thestrup-Pedersen K.

Staphylococci in dermatology
pp. 185-185(1)
Author: Noble W.C.

The potential role of Staphylococcus aureus superantigens in atopic eczema
pp. 185-185(1)
Authors: Skov L.; Strange P.; Baadsgaard O.

New clinical data on topical steroid/antibiotic combinations in atopic eczema
pp. 185-185(1)
Author: Ramsay C.A.

Staphylococcus aureus a vicious circle in atopic eczema: Implications for treatment
pp. 185-185(1)
Author: Cork M.J.

Pathogenesis of psoriasis, antipsoriatic principles with special reference to vitamin D3
pp. 186-186(1)
Author: Guilhou J.J.

Pharmacological effects of 1,24(OH)₂D₃ (tacalcitol) in vitro and in vivo
pp. 186-186(1)
Authors: Fukuoka M.; Sato H.; Ohta T.; Kiyoki M.

Epidermal barrier function -- the effects of vitamin D₃ and its analogues
pp. 186-186(1)
Author: Proksch E.

Local and systemic factors triggering psoriasis
pp. 186-186(1)
Author: Gollnick H.

Clinical experience, tacalcitol in Japan
pp. 186-187(2)
Author: Hori Y.

Clinical efficacy, safety and low irritative potential of tacalcitol; European data
pp. 187-187(1)
Author: van de Kerkhof P.C.M.

New mechanisms of action with fungicidal antifungals
pp. 187-187(1)
Author: Rashid A.

Mycotic infections in children
pp. 187-187(1)
Author: Elewski B.E.

Pityrosporum ovale (malassezia furfur): as the causative agent of seborrhoeic dermatitis; new treatment options
pp. 187-188(2)
Author: Faergemann J.

A 12 weeks treatment for dermatophyte toe-onychomycosis: terbinafine 250 mg/d or itraconazole 200 mg/d? A double blind comparative trial
pp. 188-188(1)
Authors: De Backer M.; van Lierde M.A.; De Keyser P.; De Vroey C.; Lesaffre E.

Standard or pulse therapy with terbinafine
pp. 188-188(1)
Authors: Tosti A.; Piraccini B.M.; Stinchi C.; Venturo N.; Colombo M.D.

Onychomycosis treated by terbinafine in HIV positive subjects
pp. 188-188(1)
Authors: Nandwani R.; Parnell A.; Youle M.; Hawkins D.A.; Evans E.G.; Lacey C.N.

Terbinafine in pulmonary refractory aspergillosis: compassionate cases
pp. 188-189(2)
Authors: Schiraldi G.F.; Cicero S.L.; Ferrarese M.; Colombo M.D.; Rossato D.

Employment of terbinafine inexperimental pneumocystis carinii infection
pp. 189-189(1)
Authors: Contini C.; Mutini C.; Romani R.; Colombo D.

Efficacy of terbinafine (Lamisil(R)) in the treatment of chromoblastomycosis
pp. 189-189(1)
Authors: Esterre P.; Inzan C.; Ratsioharana M.; Randriamampianina F.; Ramarcel E.; Andriantsimahavandy A.; Roig P.

Retinoids for the future: developing a new generation of receptor-selective retinoids
pp. 189-189(1)
Authors: Marks R.; Weinstein G.

''Tufted angioma'', a particular form of angioma
pp. 191-191(1)
Authors: Vanhooteghem O.; Andre J.; Bruderer P.; Touma D.; Benkirane F.; Song M.

Solitary and multiple eccrine syringofibroadenomas. Report of two cases
pp. 192-192(1)
Authors: Rongioletti F.; Parodi A.; Rebora A.; Gambini C.

Platelike primary osteoma cutis
pp. 192-192(1)
Authors: Mahler V.; Kiesewetter F.

A unique case of xanthomas due to generalized oedema
pp. 193-193(1)
Authors: Eeckhout I.; Geerts M.L.; Naeyaert J.M.

Sinus histiocytosis with massive lymphadenopathy Destombes-Rosai-Dorfman syndrome
pp. 193-193(1)
Authors: Geerts M.L.; Van de Wiele C.; Vandaele R.; Kint A.

Multiple histiocytic tumours with indeterminate cell characteristics-indeterminate cell histiocytosis
pp. 194-194(1)
Authors: Goeteyn M.; Geerts M.L.; Vanvuchelen J.

Hypocomplementemic urticarial vasculitis syndrome as an unusual intermediate stage in a patient converting from discoid to systemic lupus erythematosus
pp. 194-194(1)
Authors: Hoekzema R.; Tukkie R.; Schreuder M.C.J.; Bos J.D.; de Rie M.A.

Symptomatic atrophic papulosis in a systemic lupus erythematosus (SLE) patient
pp. 195-195(1)
Author: Torok L.

Topical tetracycline in a patient with mucous membrane pemphigoid
pp. 196-196(1)
Authors: Timmer C.; Jonkman M.F.; van der Meer J.B.

Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid
pp. 196-196(1)
Authors: Wieme N.; Geerts M.L.; Temmerman L.; Naeyaert J.M.

Mosaicism of generalized atrophic benign epidermolysis bullosa
pp. 197-197(1)
Authors: Jonkman M.F.; de Jong M.C.J.M.; Scheffer H.

Acute generalized exanthematous pustulosis
pp. 197-197(1)
Authors: De Coninck A.L.; Van Strubarq A.S.; Pipeleers-Marichal M.A.; Huyghens L.P.; Suys E.T.; Roseeuw D.I.

A case of giant condyloma accuminatum (Buschke-Loewenstein tumor)
pp. 198-198(1)
Authors: Zakopoulou N.; Tsitsi E.; Koutoudaki E.; Adamopoulou M.; Voros N.; Aroni A.; Zografakis I.

Syphilis maligna praecox
pp. 198-198(1)
Authors: Milojevic M.; Cvijetic O.

A rare case of rhino-orbito-cerebral mucormycosis with diabetic hyperosmolar coma
pp. 199-199(1)
Authors: Ogretmen Z.; Kazaz C.; Aslan L.S.; Surucuoglu S.; Ermete M.; Tabakci O.; Tarcan E.

Extensive cutaneous pseudallescheria boydii infection in an immunocompromised patient
pp. 199-199(1)
Authors: van der Endt J.D.; Vanhee J.; van Garsse L.; Klerckx P.; de Vroey C.

Lichen planus-like eruption due to ethambutol
pp. 200-200(1)
Authors: Cvijetic O.; Milojevic M.

Procainamide-induced systemic lupus erythematosus presenting as gangrene of the skin
pp. 201-201(1)
Authors: Iacobelli D.; Panine V.; Hashimoto K.

Sweet's syndrome and malignancy: a case associated with multiple oral squamous cell carcinoma
pp. 201-201(1)
Authors: Gimenez-Arnau A.; Pla C.; Camarasa J.G.; Carles J.; Barranco C.

Keratosis lichenoides chronica-like skin lesions in a case of dermatomyositis with pronounced calcinosis
pp. 201-201(1)
Authors: Lalova A.; Kamarashev J.; Obreshkova E.

Adult scurvy associated with unusual nutritional habits
pp. 202-202(1)
Authors: Goens J.; Andre J.; De Maubeuge J.; Song M.

Griscelli syndrome (GS)
pp. 202-202(1)
Authors: Luyten C.; Grossman S.; Levy J.; Schmit A.; Stene J.-J.; Song M.

Netherton's syndrome: a severe neonatal disease
pp. 203-203(1)
Authors: De Wolf K.; Ferster A.; Song M.

Follicular ichthyosis with photophobia
pp. 203-203(1)
Authors: De Moor A.; Atherton D.

Journal of the European Academy of Dermatology and Venereology

Tools

Key

Text size:

Useful pages